Prescription and Over-the-Counter Drug Product List 40TH EDITION Cumulative Supplement Number 10 : October 2020 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ACETAMINOPHEN SOLUTION;INTRAVENOUS ACETAMINOPHEN >A> AP AUROBINDO PHARMA LTD 1GM/100ML (10MG/ML) A 210969 001 Oct 21, 2020 Oct NEWA

ACETAMINOPHEN; CODEINE PHOSPHATE TABLET;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >D> AA SPECGX LLC 300MG;30MG A 040419 002 May 31, 2001 Oct CHRS >A> AA ! 300MG;30MG A 040419 002 May 31, 2001 Oct CHRS >D> TYLENOL W/ CODEINE NO. 3 >D> AA ! JANSSEN PHARMS 300MG;30MG A 085055 003 Aug 01, 1977 Oct DISC >A> @ 300MG;30MG A 085055 003 Aug 01, 1977 Oct DISC >D> TYLENOL W/ CODEINE NO. 4 >D> AA JANSSEN PHARMS 300MG;60MG A 085055 004 Aug 01, 1977 Oct DISC >A> @ 300MG;60MG A 085055 004 Aug 01, 1977 Oct DISC

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE TABLET;ORAL OXYCODONE AND ACETAMINOPHEN >D> AA LANNETT CO INC 325MG;5MG A 207333 001 Sep 25, 2017 Oct DISC >A> @ 325MG;5MG A 207333 001 Sep 25, 2017 Oct DISC >D> AA 325MG;10MG A 207333 002 Sep 25, 2017 Oct DISC >A> @ 325MG;10MG A 207333 002 Sep 25, 2017 Oct DISC >D> AA NOSTRUM LABS INC 325MG;5MG A 209385 001 Jul 02, 2018 Oct DISC >A> @ 325MG;5MG A 209385 001 Jul 02, 2018 Oct DISC >D> AA 325MG;7.5MG A 209385 002 Jul 02, 2018 Oct DISC >A> @ 325MG;7.5MG A 209385 002 Jul 02, 2018 Oct DISC >D> AA 325MG;10MG A 209385 003 Jul 02, 2018 Oct DISC >A> @ 325MG;10MG A 209385 003 Jul 02, 2018 Oct DISC

ACYCLOVIR CREAM;TOPICAL ACYCLOVIR >A> AB AMNEAL 5% A 208766 001 Nov 09, 2020 Oct NEWA

AIR POLYMER-TYPE A FOAM;INTRAUTERINE EXEM FOAM KIT >D> + @ GISKIT 10ML N 212279 001 Nov 07, 2019 Oct CMFD >A> +! 10ML N 212279 001 Nov 07, 2019 Oct CMFD

ALBUTEROL SULFATE SOLUTION;INHALATION ALBUTEROL SULFATE >D> AN AUROBINDO PHARMA LTD EQ 0.021% BASE A 211888 001 Apr 20, 2020 Oct DISC >A> @ EQ 0.021% BASE A 211888 001 Apr 20, 2020 Oct DISC >D> AN EQ 0.042% BASE A 211888 002 Apr 20, 2020 Oct DISC >A> @ EQ 0.042% BASE A 211888 002 Apr 20, 2020 Oct DISC TABLET;ORAL ALBUTEROL SULFATE >A> AB EYWA EQ 2MG BASE A 213524 001 Oct 08, 2020 Oct NEWA >A> AB EQ 4MG BASE A 213524 002 Oct 08, 2020 Oct NEWA >A> AB ZYDUS PHARMS EQ 2MG BASE A 208884 001 Oct 22, 2020 Oct NEWA >A> AB EQ 4MG BASE A 208884 002 Oct 22, 2020 Oct NEWA

ALPRAZOLAM TABLET;ORAL ALPRAZOLAM >D> @ DAVA INTL INC 0.25MG A 074174 001 Oct 19, 1993 Oct CAHN >D> @ 0.5MG A 074174 002 Oct 19, 1993 Oct CAHN >D> @ 1MG A 074174 003 Oct 19, 1993 Oct CAHN >D> @ 2MG A 074174 004 Oct 19, 1993 Oct CAHN >A> @ NOVITIUM PHARMA 0.25MG A 074174 001 Oct 19, 1993 Oct CAHN >A> @ 0.5MG A 074174 002 Oct 19, 1993 Oct CAHN >A> @ 1MG A 074174 003 Oct 19, 1993 Oct CAHN

Page 1 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ALPRAZOLAM TABLET;ORAL ALPRAZOLAM >A> @ 2MG A 074174 004 Oct 19, 1993 Oct CAHN

AMANTADINE HYDROCHLORIDE TABLET;ORAL AMANTADINE HYDROCHLORIDE >A> AB ALEMBIC PHARMS LTD 100MG A 214284 001 Oct 15, 2020 Oct NEWA

AMINOCAPROIC ACID TABLET;ORAL AMINOCAPROIC ACID >A> AB MSN 500MG A 212938 001 Nov 06, 2020 Oct NEWA

AMIODARONE HYDROCHLORIDE TABLET;ORAL PACERONE >A> AB UPSHER SMITH LABS 400MG A 075135 003 Jul 02, 2020 Oct NEWA

AMLODIPINE BESYLATE; TELMISARTAN TABLET;ORAL TELMISARTAN AND AMLODIPINE >D> AB ALEMBIC PHARMS LTD EQ 5MG BASE;40MG A 205234 001 Nov 17, 2016 Oct DISC >A> @ EQ 5MG BASE;40MG A 205234 001 Nov 17, 2016 Oct DISC >D> AB EQ 5MG BASE;80MG A 205234 003 Nov 17, 2016 Oct DISC >A> @ EQ 5MG BASE;80MG A 205234 003 Nov 17, 2016 Oct DISC >D> AB EQ 10MG BASE;40MG A 205234 002 Nov 17, 2016 Oct DISC >A> @ EQ 10MG BASE;40MG A 205234 002 Nov 17, 2016 Oct DISC >D> AB EQ 10MG BASE;80MG A 205234 004 Nov 17, 2016 Oct DISC >A> @ EQ 10MG BASE;80MG A 205234 004 Nov 17, 2016 Oct DISC

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE TABLET;ORAL DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE >D> AB BIONPHARMA INC 1.25MG;1.25MG;1.25MG;1.25MG A 210293 001 Apr 03, 2020 Oct CAHN >D> AB 1.875MG;1.875MG;1.875MG;1.875MG A 210293 002 Apr 03, 2020 Oct CAHN >D> AB 2.5MG;2.5MG;2.5MG;2.5MG A 210293 003 Apr 03, 2020 Oct CAHN >D> AB 3.75MG;3.75MG;3.75MG;3.75MG A 210293 004 Apr 03, 2020 Oct CAHN >D> AB 5MG;5MG;5MG;5MG A 210293 005 Apr 03, 2020 Oct CAHN >D> AB 7.5MG;7.5MG;7.5MG;7.5MG A 210293 006 Apr 03, 2020 Oct CAHN >A> AB USPHARMA 1.25MG;1.25MG;1.25MG;1.25MG A 210293 001 Apr 03, 2020 Oct CAHN >A> AB 1.875MG;1.875MG;1.875MG;1.875MG A 210293 002 Apr 03, 2020 Oct CAHN >A> AB 2.5MG;2.5MG;2.5MG;2.5MG A 210293 003 Apr 03, 2020 Oct CAHN >A> AB 3.75MG;3.75MG;3.75MG;3.75MG A 210293 004 Apr 03, 2020 Oct CAHN >A> AB 5MG;5MG;5MG;5MG A 210293 005 Apr 03, 2020 Oct CAHN >A> AB 7.5MG;7.5MG;7.5MG;7.5MG A 210293 006 Apr 03, 2020 Oct CAHN

AMPHETAMINE SULFATE TABLET;ORAL AMPHETAMINE SULFATE >A> AA ALKEM LABS LTD 5MG A 213720 001 Oct 27, 2020 Oct NEWA >A> AA 10MG A 213720 002 Oct 27, 2020 Oct NEWA >A> AA EPIC PHARMA LLC 5MG A 213980 001 Oct 27, 2020 Oct NEWA >A> AA 10MG A 213980 002 Oct 27, 2020 Oct NEWA

AMPICILLIN/AMPICILLIN TRIHYDRATE CAPSULE;ORAL AMPICILLIN TRIHYDRATE >D> SANDOZ EQ 250MG BASE A 064082 001 Aug 29, 1995 Oct DISC >A> @ EQ 250MG BASE A 064082 001 Aug 29, 1995 Oct DISC

APREPITANT CAPSULE;ORAL APREPITANT >A> AB TORRENT 40MG A 211835 001 Oct 21, 2020 Oct NEWA >A> AB 80MG A 211835 002 Oct 21, 2020 Oct NEWA >A> AB 125MG A 211835 003 Oct 21, 2020 Oct NEWA

Page 2 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>D> ASPIRIN; OMEPRAZOLE >D> TABLET, DELAYED RELEASE;ORAL >D> YOSPRALA >D> + GENUS LIFESCIENCES 81MG;40MG N 205103 001 Sep 14, 2016 Oct DISC >A> + @ 81MG;40MG N 205103 001 Sep 14, 2016 Oct DISC >D> +! 325MG;40MG N 205103 002 Sep 14, 2016 Oct DISC >A> + @ 325MG;40MG N 205103 002 Sep 14, 2016 Oct DISC

ATENOLOL TABLET;ORAL ATENOLOL >D> AB DAVA PHARMS INC 50MG A 073542 001 Dec 19, 1991 Oct DISC >A> @ 50MG A 073542 001 Dec 19, 1991 Oct DISC >D> AB 100MG A 073543 001 Dec 19, 1991 Oct DISC >A> @ 100MG A 073543 001 Dec 19, 1991 Oct DISC

ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE TABLET;ORAL DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE >A> AA ECI PHARMS LLC 0.025MG;2.5MG A 207128 001 Oct 21, 2020 Oct NEWA >A> AA SPECGX LLC 0.025MG;2.5MG A 213335 001 Oct 06, 2020 Oct CPOT >D> AA 2.5MG;0.025MG A 213335 001 Oct 06, 2020 Oct CPOT

AZACITIDINE POWDER;INTRAVENOUS, SUBCUTANEOUS AZACITIDINE >A> AP NANJING KING-FRIEND 100MG/VIAL A 212128 001 Nov 02, 2020 Oct NEWA

AZITHROMYCIN TABLET;ORAL AZITHROMYCIN >D> AB ALEMBIC PHARMS LTD EQ 600MG BASE A 211793 001 Jan 27, 2020 Oct DISC >A> @ EQ 600MG BASE A 211793 001 Jan 27, 2020 Oct DISC

BACLOFEN TABLET;ORAL >A> AB INNOGENIX 10MG A 212378 001 Oct 09, 2020 Oct NEWA >A> AB 20MG A 212378 002 Oct 09, 2020 Oct NEWA

BETHANECHOL CHLORIDE TABLET;ORAL BETHANECHOL CHLORIDE >D> AA WOCKHARDT 10MG A 040533 001 Sep 29, 2003 Oct DISC >A> @ 10MG A 040533 001 Sep 29, 2003 Oct DISC >D> AA 25MG A 040534 001 Sep 29, 2003 Oct DISC >A> @ 25MG A 040534 001 Sep 29, 2003 Oct DISC

BOSENTAN TABLET;ORAL BOSENTAN >D> AB ALEMBIC PHARMS LTD 62.5MG A 211461 001 Jan 23, 2020 Oct DISC >A> @ 62.5MG A 211461 001 Jan 23, 2020 Oct DISC >D> AB 125MG A 211461 002 Jan 23, 2020 Oct DISC >A> @ 125MG A 211461 002 Jan 23, 2020 Oct DISC

BROMFENAC SODIUM SOLUTION/DROPS;OPHTHALMIC BROMFENAC SODIUM >D> AT2 MYLAN EQ 0.09% ACID A 203368 001 Jun 03, 2019 Oct DISC >A> @ EQ 0.09% ACID A 203368 001 Jun 03, 2019 Oct DISC

BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE SYRUP;ORAL BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE >A> AA RHODES PHARMS 2MG/5ML;10MG/5ML;30MG/5ML A 202955 001 Nov 05, 2020 Oct NEWA

Page 3 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>D> BUPRENORPHINE HYDROCHLORIDE >D> IMPLANT;IMPLANTATION >D> PROBUPHINE >D> +! TITAN PHARMS EQ 80MG BASE/IMPLANT N 204442 001 May 26, 2016 Oct DISC >A> + @ EQ 80MG BASE/IMPLANT N 204442 001 May 26, 2016 Oct DISC

BUSULFAN INJECTABLE;INJECTION BUSULFAN >A> AP NANJING KING-FRIEND 6MG/ML A 212127 001 Oct 23, 2020 Oct NEWA

CABERGOLINE TABLET;ORAL CABERGOLINE >D> AB INGENUS PHARMS LLC 0.5MG A 204735 001 Aug 01, 2018 Oct CHRS >A> AB ! 0.5MG A 204735 001 Aug 01, 2018 Oct CHRS >D> AB ! PAR PHARM 0.5MG A 076310 001 Dec 29, 2005 Oct DISC >A> @ 0.5MG A 076310 001 Dec 29, 2005 Oct DISC

CARISOPRODOL TABLET;ORAL >D> @ FOSUN PHARMA 350MG A 081025 001 Apr 13, 1989 Oct CMFD >A> AA 350MG A 081025 001 Apr 13, 1989 Oct CMFD

CARMUSTINE INJECTABLE;INJECTION CARMUSTINE >A> AP DR REDDYS 100MG/VIAL A 213207 001 Oct 22, 2020 Oct NEWA

CEFOTETAN DISODIUM INJECTABLE;INJECTION CEFOTAN >D> AP + TELIGENT EQ 1GM BASE/VIAL N 050588 001 Dec 27, 1985 Oct CAHN >A> AP + EQ 1GM BASE/VIAL N 050588 001 Dec 27, 1985 Oct CAHN >D> AP + EQ 2GM BASE/VIAL N 050588 002 Dec 27, 1985 Oct CAHN >A> AP + EQ 2GM BASE/VIAL N 050588 002 Dec 27, 1985 Oct CAHN >D> @ EQ 10GM BASE/VIAL N 050588 003 Apr 25, 1988 Oct CAHN >A> @ EQ 10GM BASE/VIAL N 050588 003 Apr 25, 1988 Oct CAHN CEFOTAN IN PLASTIC CONTAINER >D> @ TELIGENT EQ 20MG BASE/ML N 050694 002 Jul 30, 1993 Oct CAHN >A> @ EQ 20MG BASE/ML N 050694 002 Jul 30, 1993 Oct CAHN >D> @ EQ 40MG BASE/ML N 050694 001 Jul 30, 1993 Oct CAHN >A> @ EQ 40MG BASE/ML N 050694 001 Jul 30, 1993 Oct CAHN

CEFTAZIDIME INJECTABLE;INJECTION CEFTAZIDIME >D> AP WOCKHARDT 1GM/VIAL A 065196 001 Oct 15, 2008 Oct DISC >A> @ 1GM/VIAL A 065196 001 Oct 15, 2008 Oct DISC

CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE CAPSULE;ORAL CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE >A> AB ECI PHARMS LLC 5MG;2.5MG A 213530 001 Oct 20, 2020 Oct NEWA

CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL CHLORPROMAZINE HYDROCHLORIDE >A> AB SUN PHARM 10MG A 214256 001 Oct 26, 2020 Oct NEWA >A> AB 25MG A 214256 002 Oct 26, 2020 Oct NEWA >A> AB 50MG A 214256 003 Oct 26, 2020 Oct NEWA >A> AB 100MG A 214256 004 Oct 26, 2020 Oct NEWA >A> AB 200MG A 214256 005 Oct 26, 2020 Oct NEWA

CHLORZOXAZONE TABLET;ORAL >A> AB PAR PHARM INC 750MG A 212743 001 Nov 02, 2020 Oct NEWA

Page 4 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL CIPROFLOXACIN EXTENDED RELEASE >A> @ ANI PHARMS INC 212.6MG;EQ 287.5MG BASE A 077809 002 Nov 30, 2010 Oct CMS1

CISATRACURIUM BESYLATE INJECTABLE;INJECTION CISATRACURIUM BESYLATE >A> AP SAGENT PHARMS INC EQ 2MG BASE/ML A 201836 001 Nov 06, 2020 Oct NEWA >A> AP EQ 2MG BASE/ML A 201851 001 Nov 06, 2020 Oct NEWA >A> AP EQ 10MG BASE/ML A 201836 002 Nov 06, 2020 Oct NEWA CISATRACURIUM BESYLATE PRESERVATIVE FREE >A> AP AUROBINDO PHARMA LTD EQ 2MG BASE/ML A 209665 001 Oct 27, 2020 Oct NEWA

CLARITHROMYCIN TABLET, EXTENDED RELEASE;ORAL CLARITHROMYCIN >D> AB NOSTRUM LABS INC 500MG A 203243 001 Feb 29, 2016 Oct DISC >A> @ 500MG A 203243 001 Feb 29, 2016 Oct DISC

CLINDAMYCIN PHOSPHATE GEL;TOPICAL CLINDAMYCIN PHOSPHATE >A> AB TARO PHARMS EQ 1% BASE A 214052 001 Nov 10, 2020 Oct NEWA

CLOCORTOLONE PIVALATE CREAM;TOPICAL >D> CLOCORTOLONE PIVALATE >D> AB TARO 0.1% A 206370 001 Apr 21, 2020 Oct DISC >A> @ 0.1% A 206370 001 Apr 21, 2020 Oct DISC CLODERM >D> AB +! EPI HLTH 0.1% N 017765 001 Aug 22, 1977 Oct CTEC >A> +! 0.1% N 017765 001 Aug 22, 1977 Oct CTEC

CLOFARABINE SOLUTION;INTRAVENOUS CLOFARABINE >A> AP HONG KONG 20MG/20ML (1MG/ML) A 213461 001 Oct 23, 2020 Oct NEWA

CLONIDINE TABLET, EXTENDED RELEASE;ORAL >D> CLONIDINE >D> @ TRIS PHARMA INC EQ 0.17MG BASE N 022500 001 Dec 03, 2009 Oct CTNA >D> @ EQ 0.26MG BASE N 022500 002 Dec 03, 2009 Oct CTNA >A> NEXICLON XR >A> @ TRIS PHARMA INC EQ 0.17MG BASE N 022500 001 Dec 03, 2009 Oct CTNA >A> @ EQ 0.26MG BASE N 022500 002 Dec 03, 2009 Oct CTNA

CODEINE PHOSPHATE; HYDROCHLORIDE SYRUP;ORAL PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE >A> AA QUAGEN 10MG/5ML;6.25MG/5ML A 214238 001 Oct 08, 2020 Oct NEWA

COLESEVELAM HYDROCHLORIDE TABLET;ORAL COLESEVELAM HYDROCHLORIDE >D> AB INVAGEN PHARMS 625MG A 212602 001 Apr 20, 2020 Oct DISC >A> @ 625MG A 212602 001 Apr 20, 2020 Oct DISC

CYANOCOBALAMIN SPRAY, METERED;NASAL >D> CYANOCOBALAMIN >D> AB PERRIGO UK FINCO 0.5MG/SPRAY A 212458 001 Sep 09, 2020 Oct DISC >A> @ 0.5MG/SPRAY A 212458 001 Sep 09, 2020 Oct DISC NASCOBAL >D> AB +! ENDO PHARMS INC 0.5MG/SPRAY N 021642 001 Jan 31, 2005 Oct CTEC >A> +! 0.5MG/SPRAY N 021642 001 Jan 31, 2005 Oct CTEC

Page 5 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >A> AB ALEMBIC LABS 7.5MG A 078218 003 Nov 03, 2020 Oct NEWA

DARIFENACIN HYDROBROMIDE TABLET, EXTENDED RELEASE;ORAL DARIFENACIN HYDROBROMIDE >D> @ ALAN LABS INC EQ 7.5MG BASE A 209571 002 Oct 22, 2019 Oct CAHN >D> @ EQ 15MG BASE A 209571 001 Oct 22, 2019 Oct CAHN >A> @ XIROMED EQ 7.5MG BASE A 209571 002 Oct 22, 2019 Oct CAHN >A> @ EQ 15MG BASE A 209571 001 Oct 22, 2019 Oct CAHN

DEFERASIROX TABLET, FOR SUSPENSION;ORAL DEFERASIROX >D> AB ZYDUS PHARMS 125MG A 208882 001 May 05, 2020 Oct DISC >A> @ 125MG A 208882 001 May 05, 2020 Oct DISC >D> AB 250MG A 208882 002 May 05, 2020 Oct DISC >A> @ 250MG A 208882 002 May 05, 2020 Oct DISC >D> AB 500MG A 208882 003 May 05, 2020 Oct DISC >A> @ 500MG A 208882 003 May 05, 2020 Oct DISC

DESMOPRESSIN ACETATE SPRAY, METERED;NASAL DDAVP (NEEDS NO REFRIGERATION) >D> AB +! FERRING PHARMS INC 0.01MG/SPRAY N 017922 003 Aug 07, 1996 Oct DISC >A> + @ 0.01MG/SPRAY N 017922 003 Aug 07, 1996 Oct DISC DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) >D> AB SUN PHARM 0.01MG/SPRAY A 078271 001 Dec 23, 2013 Oct CHRS >A> AB ! 0.01MG/SPRAY A 078271 001 Dec 23, 2013 Oct CHRS >D> MINIRIN >D> AB +! FERRING 0.01MG/SPRAY N 021333 001 Sep 16, 2002 Oct DISC >A> + @ 0.01MG/SPRAY N 021333 001 Sep 16, 2002 Oct DISC >D> STIMATE (NEEDS NO REFRIGERATION) >D> +! FERRING PHARMS INC 0.15MG/SPRAY N 020355 002 Oct 24, 2007 Oct DISC >A> + @ 0.15MG/SPRAY N 020355 002 Oct 24, 2007 Oct DISC

DESVENLAFAXINE SUCCINATE TABLET, EXTENDED RELEASE;ORAL DESVENLAFAXINE SUCCINATE >A> AB YICHANG HUMANWELL EQ 25MG BASE A 210014 003 Oct 13, 2020 Oct NEWA

DEXMETHYLPHENIDATE HYDROCHLORIDE TABLET;ORAL DEXMETHYLPHENIDATE HYDROCHLORIDE >D> @ BIONPHARMA INC 5MG A 209754 001 Mar 24, 2020 Oct CAHN >D> @ 10MG A 209754 002 Mar 24, 2020 Oct CAHN >A> @ USPHARMA 5MG A 209754 001 Mar 24, 2020 Oct CAHN >A> @ 10MG A 209754 002 Mar 24, 2020 Oct CAHN

DICLOFENAC CAPSULE;ORAL ZORVOLEX >D> + ZYLA 18MG N 204592 001 Oct 18, 2013 Oct DISC >A> + @ 18MG N 204592 001 Oct 18, 2013 Oct DISC

DICLOFENAC POTASSIUM TABLET;ORAL DICLOFENAC POTASSIUM >A> AB AMICI 50MG A 076561 001 Mar 18, 2004 Oct CAHN >D> AB ANDA REPOSITORY 50MG A 076561 001 Mar 18, 2004 Oct CAHN

DIMETHYL FUMARATE CAPSULE, DELAYED RELEASE;ORAL DIMETHYL FUMARATE >A> AB TWI PHARMS 120MG A 210382 001 Oct 14, 2020 Oct NEWA >A> AB 240MG A 210382 002 Oct 14, 2020 Oct NEWA

Page 6 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DISULFIRAM TABLET;ORAL DISULFIRAM >D> @ HIKMA 250MG A 202652 001 Feb 05, 2014 Oct CMFD >A> AB 250MG A 202652 001 Feb 05, 2014 Oct CMFD >D> @ 500MG A 202652 002 Feb 05, 2014 Oct CMFD >A> AB 500MG A 202652 002 Feb 05, 2014 Oct CMFD

DOFETILIDE CAPSULE;ORAL DOFETILIDE >D> AB PRINSTON INC 0.125MG A 211223 001 Dec 17, 2019 Oct DISC >A> @ 0.125MG A 211223 001 Dec 17, 2019 Oct DISC >D> AB 0.25MG A 211223 002 Dec 17, 2019 Oct DISC >A> @ 0.25MG A 211223 002 Dec 17, 2019 Oct DISC >D> AB 0.5MG A 211223 003 Dec 17, 2019 Oct DISC >A> @ 0.5MG A 211223 003 Dec 17, 2019 Oct DISC

DONEPEZIL HYDROCHLORIDE TABLET, ORALLY DISINTEGRATING;ORAL HYDROCHLORIDE >D> AB UNICHEM 5MG A 204831 001 Nov 10, 2016 Oct DISC >A> @ 5MG A 204831 001 Nov 10, 2016 Oct DISC >D> AB 10MG A 204831 002 Nov 10, 2016 Oct DISC >A> @ 10MG A 204831 002 Nov 10, 2016 Oct DISC TABLET;ORAL DONEPEZIL HYDROCHLORIDE >D> AB HISUN PHARM HANGZHOU 23MG A 202410 001 Mar 24, 2017 Oct DISC >A> @ 23MG A 202410 001 Mar 24, 2017 Oct DISC >D> AB UNICHEM 5MG A 203656 001 Jun 23, 2016 Oct DISC >A> @ 5MG A 203656 001 Jun 23, 2016 Oct DISC >D> AB 10MG A 203656 002 Jun 23, 2016 Oct DISC >A> @ 10MG A 203656 002 Jun 23, 2016 Oct DISC

DORZOLAMIDE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE >A> AT AKORN EQ 2% BASE A 077846 001 Oct 28, 2008 Oct CAHN >D> AT HI TECH PHARMA EQ 2% BASE A 077846 001 Oct 28, 2008 Oct CAHN

DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE SOLUTION/DROPS;OPHTHALMIC COSOPT >A> AT +! AKORN EQ 2% BASE;EQ 0.5% BASE N 020869 001 Apr 07, 1998 Oct CAHN >D> AT +! OAK PHARMS INC EQ 2% BASE;EQ 0.5% BASE N 020869 001 Apr 07, 1998 Oct CAHN DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE >A> AT AKORN EQ 2% BASE;EQ 0.5% BASE A 077847 001 Oct 28, 2008 Oct CAHN >D> AT HI TECH PHARMA EQ 2% BASE;EQ 0.5% BASE A 077847 001 Oct 28, 2008 Oct CAHN

DOXEPIN HYDROCHLORIDE CAPSULE;ORAL HYDROCHLORIDE >A> AB EPIC PHARMA LLC EQ 10MG BASE A 210675 001 Oct 16, 2020 Oct NEWA >A> AB EQ 25MG BASE A 210675 002 Oct 16, 2020 Oct NEWA >A> AB EQ 100MG BASE A 210675 003 Oct 16, 2020 Oct NEWA >D> AB LANNETT CO INC EQ 10MG BASE A 212997 001 Jul 24, 2020 Oct DISC >A> @ EQ 10MG BASE A 212997 001 Jul 24, 2020 Oct DISC >D> AB EQ 25MG BASE A 212997 002 Jul 24, 2020 Oct DISC >A> @ EQ 25MG BASE A 212997 002 Jul 24, 2020 Oct DISC >D> AB EQ 50MG BASE A 212997 003 Jul 24, 2020 Oct DISC >A> @ EQ 50MG BASE A 212997 003 Jul 24, 2020 Oct DISC >D> AB EQ 75MG BASE A 212997 004 Jul 24, 2020 Oct DISC >A> @ EQ 75MG BASE A 212997 004 Jul 24, 2020 Oct DISC >D> AB EQ 100MG BASE A 212997 005 Jul 24, 2020 Oct DISC >A> @ EQ 100MG BASE A 212997 005 Jul 24, 2020 Oct DISC

Page 7 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL DORYX >D> + @ MAYNE PHARMA EQ 80MG BASE N 050795 004 Apr 11, 2013 Oct CMFD >A> + EQ 80MG BASE N 050795 004 Apr 11, 2013 Oct CMFD TABLET;ORAL DOXYCYCLINE HYCLATE >D> AB ALEMBIC PHARMS LTD EQ 100MG BASE A 210536 001 May 14, 2020 Oct DISC >A> @ EQ 100MG BASE A 210536 001 May 14, 2020 Oct DISC >D> AB MYLAN EQ 75MG BASE A 209987 001 Oct 05, 2020 Oct DISC >A> @ EQ 75MG BASE A 209987 001 Oct 05, 2020 Oct DISC >D> AB EQ 150MG BASE A 209987 002 Oct 05, 2020 Oct DISC >A> @ EQ 150MG BASE A 209987 002 Oct 05, 2020 Oct DISC

DRONABINOL SOLUTION;ORAL SYNDROS >A> +! BENUVIA 5MG/ML N 205525 001 Mar 23, 2017 Oct CAHN >D> +! GUA ZHUANG 5MG/ML N 205525 001 Mar 23, 2017 Oct CAHN

EDROPHONIUM CHLORIDE INJECTABLE;INJECTION TENSILON >D> + @ TELIGENT 10MG/ML N 007959 001 May 03, 1951 Oct CAHN >A> + @ 10MG/ML N 007959 001 May 03, 1951 Oct CAHN TENSILON PRESERVATIVE FREE >D> + @ TELIGENT 10MG/ML N 007959 002 May 03, 1951 Oct CAHN >A> + @ 10MG/ML N 007959 002 May 03, 1951 Oct CAHN

ELETRIPTAN HYDROBROMIDE TABLET;ORAL ELETRIPTAN HYDROBROMIDE >D> AB AMNEAL PHARMS CO EQ 20MG BASE A 206787 001 May 25, 2018 Oct DISC >A> @ EQ 20MG BASE A 206787 001 May 25, 2018 Oct DISC >D> AB EQ 40MG BASE A 206787 002 May 25, 2018 Oct DISC >A> @ EQ 40MG BASE A 206787 002 May 25, 2018 Oct DISC

ENALAPRIL MALEATE TABLET;ORAL ENALAPRIL MALEATE >D> AB NOSTRUM LABS INC 2.5MG A 075178 002 Mar 23, 2001 Oct DISC >A> @ 2.5MG A 075178 002 Mar 23, 2001 Oct DISC >D> AB 5MG A 075178 001 Mar 23, 2001 Oct DISC >A> @ 5MG A 075178 001 Mar 23, 2001 Oct DISC >D> AB 10MG A 075178 003 Mar 23, 2001 Oct DISC >A> @ 10MG A 075178 003 Mar 23, 2001 Oct DISC >D> AB 20MG A 075178 004 Mar 23, 2001 Oct DISC >A> @ 20MG A 075178 004 Mar 23, 2001 Oct DISC

ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE TABLET;ORAL ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE >D> AB NOSTRUM LABS INC 5MG;12.5MG A 076486 001 Oct 27, 2004 Oct DISC >A> @ 5MG;12.5MG A 076486 001 Oct 27, 2004 Oct DISC >D> AB 10MG;25MG A 076486 002 Oct 27, 2004 Oct DISC >A> @ 10MG;25MG A 076486 002 Oct 27, 2004 Oct DISC

ENTECAVIR TABLET;ORAL ENTECAVIR >D> AB SUNSHINE 0.5MG A 211978 001 May 20, 2020 Oct DISC >A> @ 0.5MG A 211978 001 May 20, 2020 Oct DISC >D> AB 1MG A 211978 002 May 20, 2020 Oct DISC >A> @ 1MG A 211978 002 May 20, 2020 Oct DISC

Page 8 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

EPHEDRINE SULFATE SOLUTION;INTRAVENOUS EPHEDRINE SULFATE >A> +! NEVAKAR 50MG/10ML (5MG/ML) N 213994 001 Oct 16, 2020 Oct NEWA

ERLOTINIB HYDROCHLORIDE TABLET;ORAL ERLOTINIB HYDROCHLORIDE >D> AB TEVA PHARMS USA EQ 100MG BASE A 091059 002 Aug 28, 2015 Oct CAHN >D> AB EQ 150MG BASE A 091059 003 Aug 28, 2015 Oct CAHN >A> AB TEVA PHARMS USA INC EQ 25MG BASE A 091059 001 Nov 09, 2020 Oct NEWA >A> AB EQ 100MG BASE A 091059 002 Aug 28, 2015 Oct CAHN >A> AB EQ 150MG BASE A 091059 003 Aug 28, 2015 Oct CAHN

ERYTHROMYCIN SOLUTION;TOPICAL ERYTHRA-DERM >D> @ MLV 2% A 062687 001 Feb 05, 1988 Oct CAHN >A> @ SAPTALIS PHARMS 2% A 062687 001 Feb 05, 1988 Oct CAHN

ESTAZOLAM TABLET;ORAL >A> AB NOVITIUM PHARMA 1MG A 074826 001 Jul 03, 1997 Oct CAHN >A> AB 2MG A 074826 002 Jul 03, 1997 Oct CAHN >D> AB PAR PHARM 1MG A 074826 001 Jul 03, 1997 Oct CAHN >D> AB 2MG A 074826 002 Jul 03, 1997 Oct CAHN

ETHACRYNIC ACID TABLET;ORAL ETHACRYNIC ACID >A> AB STRIDES PHARMA 25MG A 213240 001 Oct 19, 2020 Oct NEWA

ETHINYL ESTRADIOL; LEVONORGESTREL TABLET;ORAL >A> DOLISHALE >A> AB NOVAST LABS 0.02MG;0.09MG A 091692 001 Oct 22, 2020 Oct NEWA TABLET;ORAL-28 LEVONORGESTREL AND ETHINYL ESTRADIOL >A> AB NAARI PTE LTD 0.03MG;0.15MG A 207033 001 Oct 09, 2020 Oct NEWA

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE CAPSULE;ORAL GEMMILY >A> AB CHEMO RESEARCH SL 0.02MG;1MG A 213317 001 Nov 09, 2020 Oct NFTG TAYTULLA >D> +! APIL 0.02MG;1MG N 204426 001 Apr 19, 2013 Oct CFTG >A> AB +! 0.02MG;1MG N 204426 001 Apr 19, 2013 Oct CFTG TABLET;ORAL NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL >D> AB MYLAN LABS LTD 0.005MG;1MG A 207259 001 Dec 27, 2016 Oct DISC >A> @ 0.005MG;1MG A 207259 001 Dec 27, 2016 Oct DISC

EXEMESTANE TABLET;ORAL EXEMESTANE >D> AB QILU 25MG A 213547 001 Apr 13, 2020 Oct DISC >A> @ 25MG A 213547 001 Apr 13, 2020 Oct DISC

EZETIMIBE TABLET;ORAL EZETIMIBE >A> AB SCIEGEN PHARMS INC 10MG A 210673 001 Oct 23, 2020 Oct NEWA

FAMCICLOVIR TABLET;ORAL FAMCICLOVIR >D> AB MYLAN 125MG A 201333 001 Mar 24, 2011 Oct DISC >A> @ 125MG A 201333 001 Mar 24, 2011 Oct DISC >D> AB 250MG A 201333 002 Mar 24, 2011 Oct DISC >A> @ 250MG A 201333 002 Mar 24, 2011 Oct DISC

Page 9 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FAMCICLOVIR TABLET;ORAL FAMCICLOVIR >D> AB 500MG A 201333 003 Mar 24, 2011 Oct DISC >A> @ 500MG A 201333 003 Mar 24, 2011 Oct DISC

FEBUXOSTAT TABLET;ORAL FEBUXOSTAT >A> AB DR REDDYS LABS LTD 40MG A 205374 001 Oct 22, 2020 Oct NEWA >A> AB 80MG A 205374 002 Oct 22, 2020 Oct NEWA

FENOFIBRATE CAPSULE;ORAL ANTARA (MICRONIZED) >D> + LUPIN 90MG N 021695 005 Oct 18, 2013 Oct CHRS >A> +! 90MG N 021695 005 Oct 18, 2013 Oct CHRS FENOFIBRATE (MICRONIZED) >A> AB ALEMBIC PHARMS LTD 67MG A 213842 001 Oct 19, 2020 Oct NEWA >A> AB 134MG A 213842 002 Oct 19, 2020 Oct NEWA >A> AB 200MG A 213842 003 Oct 19, 2020 Oct NEWA TABLET;ORAL FENOFIBRATE >D> AB ALEMBIC PHARMS LTD 54MG A 213252 001 Jan 17, 2020 Oct DISC >A> @ 54MG A 213252 001 Jan 17, 2020 Oct DISC >D> AB 160MG A 213252 002 Jan 17, 2020 Oct DISC >A> @ 160MG A 213252 002 Jan 17, 2020 Oct DISC

FENTANYL FILM, EXTENDED RELEASE;TRANSDERMAL FENTANYL-100 >D> AB 3M DRUG DELIVERY 100MCG/HR A 202097 005 Nov 04, 2016 Oct CAHN >A> AB KINDEVA 100MCG/HR A 202097 005 Nov 04, 2016 Oct CAHN FENTANYL-12 >D> AB 3M DRUG DELIVERY 12.5MCG/HR A 202097 001 Nov 04, 2016 Oct CAHN >A> AB KINDEVA 12.5MCG/HR A 202097 001 Nov 04, 2016 Oct CAHN FENTANYL-25 >D> AB 3M DRUG DELIVERY 25MCG/HR A 202097 002 Nov 04, 2016 Oct CAHN >A> AB KINDEVA 25MCG/HR A 202097 002 Nov 04, 2016 Oct CAHN FENTANYL-50 >D> AB 3M DRUG DELIVERY 50MCG/HR A 202097 003 Nov 04, 2016 Oct CAHN >A> AB KINDEVA 50MCG/HR A 202097 003 Nov 04, 2016 Oct CAHN FENTANYL-75 >D> AB 3M DRUG DELIVERY 75MCG/HR A 202097 004 Nov 04, 2016 Oct CAHN >A> AB KINDEVA 75MCG/HR A 202097 004 Nov 04, 2016 Oct CAHN

FERRIC CARBOXYMALTOSE >D> INJECTABLE;INTRAVENOUS >D> INJECTAFER >D> +! AM REGENT 750MG IRON/15ML (50MG IRON/ML) N 203565 001 Jul 25, 2013 Oct CDFR >A> SOLUTION;INTRAVENOUS >A> INJECTAFER >A> +! AM REGENT 750MG IRON/15ML (50MG IRON/ML) N 203565 001 Jul 25, 2013 Oct CDFR >A> +! 500MG IRON/10ML (50MG IRON/ML) N 203565 002 Oct 08, 2020 Oct NEWA

FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL FINGOLIMOD HYDROCHLORIDE >A> AB ACCORD HLTHCARE EQ 0.5MG BASE A 207991 001 Oct 28, 2020 Oct NEWA >A> AB ZYDUS PHARMS EQ 0.5MG BASE A 207994 001 Oct 14, 2020 Oct NEWA

FLUCYTOSINE CAPSULE;ORAL FLUCYTOSINE >D> AB RECIPHARM 250MG A 207536 001 Jun 18, 2018 Oct DISC >A> @ 250MG A 207536 001 Jun 18, 2018 Oct DISC >D> AB 500MG A 207536 002 Jun 18, 2018 Oct DISC >A> @ 500MG A 207536 002 Jun 18, 2018 Oct DISC >D> AB STRIDES PHARMA 250MG A 212632 001 Apr 17, 2020 Oct DISC >A> @ 250MG A 212632 001 Apr 17, 2020 Oct DISC >D> AB 500MG A 212632 002 Apr 17, 2020 Oct DISC

Page 10 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FLUCYTOSINE CAPSULE;ORAL FLUCYTOSINE >A> @ 500MG A 212632 002 Apr 17, 2020 Oct DISC

FLUOROURACIL INJECTABLE;INJECTION FLUOROURACIL >D> AP ! TEVA PHARMS USA 2.5GM/50ML (50MG/ML) A 040334 001 Feb 25, 2000 Oct DISC >A> @ 2.5GM/50ML (50MG/ML) A 040334 001 Feb 25, 2000 Oct DISC >D> AP ! 5GM/100ML (50MG/ML) A 040334 002 Feb 25, 2000 Oct DISC >A> @ 5GM/100ML (50MG/ML) A 040334 002 Feb 25, 2000 Oct DISC

FLUPHENAZINE HYDROCHLORIDE TABLET;ORAL FLUPHENAZINE HYDROCHLORIDE >D> AB MYLAN 1MG A 089804 002 Aug 12, 1988 Oct DISC >A> @ 1MG A 089804 002 Aug 12, 1988 Oct DISC >D> AB 2.5MG A 089804 003 Aug 12, 1988 Oct DISC >A> @ 2.5MG A 089804 003 Aug 12, 1988 Oct DISC >D> AB 5MG A 089804 004 Aug 12, 1988 Oct DISC >A> @ 5MG A 089804 004 Aug 12, 1988 Oct DISC >D> AB 10MG A 089804 001 Aug 12, 1988 Oct DISC >A> @ 10MG A 089804 001 Aug 12, 1988 Oct DISC

GABAPENTIN CAPSULE;ORAL >D> AB MYLAN 100MG A 090158 001 Feb 14, 2011 Oct DISC >A> @ 100MG A 090158 001 Feb 14, 2011 Oct DISC >D> AB 300MG A 090158 002 Feb 14, 2011 Oct DISC >A> @ 300MG A 090158 002 Feb 14, 2011 Oct DISC >D> AB 400MG A 090158 003 Feb 14, 2011 Oct DISC >A> @ 400MG A 090158 003 Feb 14, 2011 Oct DISC

GLYBURIDE TABLET;ORAL GLYBURIDE >D> AB1 AUROBINDO PHARMA 1.25MG A 077537 001 Oct 18, 2007 Oct DISC >A> @ 1.25MG A 077537 001 Oct 18, 2007 Oct DISC >D> AB1 2.5MG A 077537 002 Oct 18, 2007 Oct DISC >A> @ 2.5MG A 077537 002 Oct 18, 2007 Oct DISC >D> AB1 5MG A 077537 003 Oct 18, 2007 Oct DISC >A> @ 5MG A 077537 003 Oct 18, 2007 Oct DISC

HYDRALAZINE HYDROCHLORIDE INJECTABLE;INJECTION HYDRALAZINE HYDROCHLORIDE >D> @ AM REGENT 20MG/ML A 040136 001 Jun 30, 1997 Oct CMFD >A> AP 20MG/ML A 040136 001 Jun 30, 1997 Oct CMFD

HYDROCHLOROTHIAZIDE CAPSULE;ORAL HYDROCHLOROTHIAZIDE >D> AB ALEMBIC PHARMS LTD 12.5MG A 200645 001 Nov 30, 2010 Oct DISC >A> @ 12.5MG A 200645 001 Nov 30, 2010 Oct DISC

HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL IRBESARTAN AND HYDROCHLOROTHIAZIDE >D> AB UNICHEM 12.5MG;150MG A 207018 001 Sep 19, 2017 Oct DISC >A> @ 12.5MG;150MG A 207018 001 Sep 19, 2017 Oct DISC >D> AB 12.5MG;300MG A 207018 002 Sep 19, 2017 Oct DISC >A> @ 12.5MG;300MG A 207018 002 Sep 19, 2017 Oct DISC

Page 11 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM TABLET;ORAL LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE >D> AB UNICHEM 12.5MG;50MG A 204832 001 Jul 21, 2017 Oct DISC >A> @ 12.5MG;50MG A 204832 001 Jul 21, 2017 Oct DISC >D> AB 12.5MG;100MG A 204832 002 Jul 21, 2017 Oct DISC >A> @ 12.5MG;100MG A 204832 002 Jul 21, 2017 Oct DISC >D> AB 25MG;100MG A 204832 003 Jul 21, 2017 Oct DISC >A> @ 25MG;100MG A 204832 003 Jul 21, 2017 Oct DISC

HYDROCORTISONE ENEMA;RECTAL COLOCORT >A> AB BENUVIA 100MG/60ML A 075172 001 Dec 03, 1999 Oct CAHN >D> AB PADDOCK LLC 100MG/60ML A 075172 001 Dec 03, 1999 Oct CAHN

HYDROMORPHONE HYDROCHLORIDE SOLUTION;ORAL HYDROMORPHONE HYDROCHLORIDE >D> AA LANNETT CO INC 5MG/5ML A 207108 001 Apr 22, 2020 Oct DISC >A> @ 5MG/5ML A 207108 001 Apr 22, 2020 Oct DISC TABLET;ORAL HYDROMORPHONE HYDROCHLORIDE >D> AB NOSTRUM LABS INC 8MG A 076723 001 Oct 18, 2005 Oct DISC >A> @ 8MG A 076723 001 Oct 18, 2005 Oct DISC

INDAPAMIDE >D> TABLET;ORAL >D> INDAPAMIDE >D> AB ANI PHARMS INC 1.25MG A 075201 001 Dec 04, 1998 Oct DISC >A> @ 1.25MG A 075201 001 Dec 04, 1998 Oct DISC >D> AB 2.5MG A 075201 002 Dec 04, 1998 Oct DISC >A> @ 2.5MG A 075201 002 Dec 04, 1998 Oct DISC

INDOMETHACIN SODIUM INJECTABLE;INJECTION >D> INDOCIN >D> AP +! RECORDATI RARE EQ 1MG BASE/VIAL N 018878 001 Jan 30, 1985 Oct DISC >A> + @ EQ 1MG BASE/VIAL N 018878 001 Jan 30, 1985 Oct DISC INDOMETHACIN SODIUM >D> AP NAVINTA LLC EQ 1MG BASE/VIAL A 206561 001 Jul 19, 2017 Oct CHRS >A> AP ! EQ 1MG BASE/VIAL A 206561 001 Jul 19, 2017 Oct CHRS

IRBESARTAN TABLET;ORAL IRBESARTAN >D> AB UNICHEM 75MG A 203020 001 Dec 07, 2015 Oct DISC >A> @ 75MG A 203020 001 Dec 07, 2015 Oct DISC >D> AB 150MG A 203020 002 Dec 07, 2015 Oct DISC >A> @ 150MG A 203020 002 Dec 07, 2015 Oct DISC >D> AB 300MG A 203020 003 Dec 07, 2015 Oct DISC >A> @ 300MG A 203020 003 Dec 07, 2015 Oct DISC

IRINOTECAN HYDROCHLORIDE INJECTABLE;INJECTION IRINOTECAN HYDROCHLORIDE >A> AP EUGIA PHARMA 40MG/2ML (20MG/ML) A 213278 001 Nov 02, 2020 Oct NEWA >A> AP 100MG/5ML (20MG/ML) A 213278 002 Nov 02, 2020 Oct NEWA >A> AP 300MG/15ML (20MG/ML) A 213278 003 Nov 02, 2020 Oct NEWA

ISOSORBIDE DINITRATE >D> CAPSULE, EXTENDED RELEASE;ORAL >D> DILATRATE-SR >D> +! AUXILIUM PHARMS LLC 40MG N 019790 001 Sep 02, 1988 Oct DISC >A> + @ 40MG N 019790 001 Sep 02, 1988 Oct DISC

Page 12 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

KETOROLAC TROMETHAMINE INJECTABLE;INJECTION KETOROLAC TROMETHAMINE >A> @ ATLANTIDE 30MG/ML A 077943 001 Mar 27, 2007 Oct CAHN >A> AP AUROBINDO PHARMA LTD 15MG/ML A 212939 001 Oct 20, 2020 Oct NEWA >A> AP 30MG/ML A 212939 002 Oct 20, 2020 Oct NEWA >D> @ WOCKHARDT 30MG/ML A 077943 001 Mar 27, 2007 Oct CAHN

LABETALOL HYDROCHLORIDE TABLET;ORAL LABETALOL HYDROCHLORIDE >D> @ HERITAGE PHARMA 300MG A 074787 003 Aug 03, 1998 Oct CMFD >A> AB 300MG A 074787 003 Aug 03, 1998 Oct CMFD

LEUCOVORIN CALCIUM TABLET;ORAL LEUCOVORIN CALCIUM >A> AB LEADING PHARMA LLC EQ 5MG BASE A 213929 001 Oct 22, 2020 Oct NEWA >A> AB EQ 10MG BASE A 213929 002 Oct 22, 2020 Oct NEWA >A> AB EQ 15MG BASE A 213929 003 Oct 22, 2020 Oct NEWA >A> AB EQ 25MG BASE A 213929 004 Oct 22, 2020 Oct NEWA

LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL FETZIMA >D> + ALLERGAN EQ 20MG BASE N 204168 001 Jul 25, 2013 Oct CTEC >A> AB + EQ 20MG BASE N 204168 001 Jul 25, 2013 Oct CTEC >D> + EQ 40MG BASE N 204168 002 Jul 25, 2013 Oct CTEC >A> AB + EQ 40MG BASE N 204168 002 Jul 25, 2013 Oct CTEC >D> + EQ 80MG BASE N 204168 003 Jul 25, 2013 Oct CTEC >A> AB + EQ 80MG BASE N 204168 003 Jul 25, 2013 Oct CTEC >D> +! EQ 120MG BASE N 204168 004 Jul 25, 2013 Oct CTEC >A> AB +! EQ 120MG BASE N 204168 004 Jul 25, 2013 Oct CTEC LEVOMILNACIPRAN HYDROCHLORIDE >A> AB HIKMA EQ 20MG BASE A 210732 001 Nov 05, 2020 Oct NEWA >A> AB EQ 40MG BASE A 210732 002 Nov 05, 2020 Oct NEWA >A> AB EQ 80MG BASE A 210732 003 Nov 05, 2020 Oct NEWA >A> AB EQ 120MG BASE A 210732 004 Nov 05, 2020 Oct NEWA

LEVOTHYROXINE SODIUM CAPSULE;ORAL LEVOTHYROXINE SODIUM >A> AB TEVA PHARMS USA INC 0.075MG A 211369 001 Oct 28, 2020 Oct NFTG >A> AB 0.15MG A 211369 002 Oct 28, 2020 Oct NFTG TIROSINT >D> + INSTITUT BIOCHIMIQUE 0.075MG N 021924 004 Oct 13, 2006 Oct CFTG >A> AB + 0.075MG N 021924 004 Oct 13, 2006 Oct CFTG >D> + 0.15MG N 021924 007 Oct 13, 2006 Oct CFTG >A> AB + 0.15MG N 021924 007 Oct 13, 2006 Oct CFTG TABLET;ORAL LEVOTHYROXINE SODIUM >A> AB2 ACCORD HLTHCARE 0.025MG A 212399 001 Oct 19, 2020 Oct NEWA >A> AB2 0.05MG A 212399 002 Oct 19, 2020 Oct NEWA >A> AB2 0.075MG A 212399 003 Oct 19, 2020 Oct NEWA >A> AB2 0.088MG A 212399 004 Oct 19, 2020 Oct NEWA >A> AB2 0.1MG A 212399 005 Oct 19, 2020 Oct NEWA >A> AB2 0.112MG A 212399 006 Oct 19, 2020 Oct NEWA >A> AB2 0.125MG A 212399 007 Oct 19, 2020 Oct NEWA >A> AB2 0.137MG A 212399 008 Oct 19, 2020 Oct NEWA >A> AB2 0.15MG A 212399 009 Oct 19, 2020 Oct NEWA >A> AB2 0.175MG A 212399 010 Oct 19, 2020 Oct NEWA >A> AB2 0.2MG A 212399 011 Oct 19, 2020 Oct NEWA >A> AB2 0.3MG A 212399 012 Oct 19, 2020 Oct NEWA

LIDOCAINE HYDROCHLORIDE GEL;OPHTHALMIC AKTEN >D> +! AKORN 3.5% N 022221 001 Oct 07, 2008 Oct CAHN >A> +! 3.5% N 022221 001 Oct 07, 2008 Oct CAHN

Page 13 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LINDANE LOTION;TOPICAL LINDANE >D> ! OLTA PHARMS 1% A 087313 001 Dec 17, 1981 Oct DISC >A> @ 1% A 087313 001 Dec 17, 1981 Oct DISC SHAMPOO;TOPICAL LINDANE >D> AT OLTA PHARMS 1% A 087266 001 Dec 17, 1981 Oct DISC >A> @ 1% A 087266 001 Dec 17, 1981 Oct DISC >D> AT ! WOCKHARDT BIO AG 1% A 088191 001 Sep 18, 1984 Oct CTEC >A> ! 1% A 088191 001 Sep 18, 1984 Oct CTEC

LINEZOLID FOR SUSPENSION;ORAL ZYVOX >A> AB +! PFIZER 100MG/5ML N 021132 001 Apr 18, 2000 Oct CAHN >D> AB +! PHARMACIA AND UPJOHN 100MG/5ML N 021132 001 Apr 18, 2000 Oct CAHN SOLUTION;INTRAVENOUS ZYVOX >A> AP + PFIZER 200MG/100ML (2MG/ML) N 021131 001 Apr 18, 2000 Oct CAHN >A> + @ 400MG/200ML (2MG/ML) N 021131 002 Apr 18, 2000 Oct CAHN >A> AP +! 600MG/300ML (2MG/ML) N 021131 003 Apr 18, 2000 Oct CAHN >D> AP + PHARMACIA AND UPJOHN 200MG/100ML (2MG/ML) N 021131 001 Apr 18, 2000 Oct CAHN >D> + @ 400MG/200ML (2MG/ML) N 021131 002 Apr 18, 2000 Oct CAHN >D> AP +! 600MG/300ML (2MG/ML) N 021131 003 Apr 18, 2000 Oct CAHN TABLET;ORAL ZYVOX >A> + @ PFIZER 400MG N 021130 001 Apr 18, 2000 Oct CAHN >A> AB +! 600MG N 021130 002 Apr 18, 2000 Oct CAHN >D> + @ PHARMACIA AND UPJOHN 400MG N 021130 001 Apr 18, 2000 Oct CAHN >D> AB +! 600MG N 021130 002 Apr 18, 2000 Oct CAHN

LISINOPRIL TABLET;ORAL LISINOPRIL >A> AB ATLANTIDE 2.5MG A 078402 001 Apr 19, 2007 Oct CAHN >A> AB 5MG A 078402 002 Apr 19, 2007 Oct CAHN >A> AB 10MG A 078402 003 Apr 19, 2007 Oct CAHN >A> AB 20MG A 078402 004 Apr 19, 2007 Oct CAHN >A> AB 30MG A 078402 005 Apr 19, 2007 Oct CAHN >A> AB 40MG A 078402 006 Apr 19, 2007 Oct CAHN >A> AB PRINSTON INC 2.5MG A 076164 004 Jul 01, 2002 Oct CMS1 >A> AB 5MG A 076164 005 Jul 01, 2002 Oct CMS1 >A> AB 10MG A 076164 006 Jul 01, 2002 Oct CMS1 >D> AB WOCKHARDT 2.5MG A 078402 001 Apr 19, 2007 Oct CAHN >D> AB 5MG A 078402 002 Apr 19, 2007 Oct CAHN >D> AB 10MG A 078402 003 Apr 19, 2007 Oct CAHN >D> AB 20MG A 078402 004 Apr 19, 2007 Oct CAHN >D> AB 30MG A 078402 005 Apr 19, 2007 Oct CAHN >D> AB 40MG A 078402 006 Apr 19, 2007 Oct CAHN

LITHIUM CARBONATE TABLET, EXTENDED RELEASE;ORAL LITHIUM CARBONATE >D> AB ALEMBIC PHARMS LTD 300MG A 204445 001 Jun 10, 2015 Oct DISC >A> @ 300MG A 204445 001 Jun 10, 2015 Oct DISC

LOSARTAN POTASSIUM TABLET;ORAL LOSARTAN POTASSIUM >D> AB UNICHEM 25MG A 203030 001 Oct 14, 2015 Oct DISC >A> @ 25MG A 203030 001 Oct 14, 2015 Oct DISC >D> AB 50MG A 203030 002 Oct 14, 2015 Oct DISC >A> @ 50MG A 203030 002 Oct 14, 2015 Oct DISC >D> AB 100MG A 203030 003 Oct 14, 2015 Oct DISC >A> @ 100MG A 203030 003 Oct 14, 2015 Oct DISC

Page 14 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LOTEPREDNOL ETABONATE SUSPENSION/DROPS;OPHTHALMIC >A> EYSUVIS >A> +! KALA PHARMS INC 0.25% N 210933 001 Oct 26, 2020 Oct NEWA

MAGNESIUM SULFATE INJECTABLE;INJECTION MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER >A> AP B BRAUN MEDICAL INC 1GM/100ML A 207966 001 Oct 27, 2020 Oct NEWA

MANNITOL POWDER;INHALATION >A> BRONCHITOL >A> +! CHIESI 40MG N 202049 001 Oct 30, 2020 Oct NEWA

MECLIZINE HYDROCHLORIDE TABLET;ORAL MECLIZINE HYDROCHLORIDE >A> AA ANNORA PHARMA 12.5MG A 087128 002 Jun 03, 1981 Oct CMS1

MEFENAMIC ACID CAPSULE;ORAL MEFENAMIC ACID >D> @ BRECKENRIDGE 250MG A 090359 001 Feb 05, 2013 Oct CAHN >A> @ NOSTRUM LABS INC 250MG A 090359 001 Feb 05, 2013 Oct CAHN

MELOXICAM CAPSULE;ORAL MELOXICAM >D> AB LUPIN LTD 5MG A 209487 001 Jun 01, 2020 Oct CTEC >A> 5MG A 209487 001 Jun 01, 2020 Oct CTEC >D> AB 10MG A 209487 002 Jun 01, 2020 Oct CHRS >A> ! 10MG A 209487 002 Jun 01, 2020 Oct CTEC >A> AB ! 10MG A 209487 002 Jun 01, 2020 Oct CHRS >D> VIVLODEX >D> AB + ZYLA 5MG N 207233 001 Oct 22, 2015 Oct DISC >A> + @ 5MG N 207233 001 Oct 22, 2015 Oct DISC >D> AB +! 10MG N 207233 002 Oct 22, 2015 Oct DISC >A> + @ 10MG N 207233 002 Oct 22, 2015 Oct DISC TABLET;ORAL MELOXICAM >D> AB BRECKENRIDGE PHARM 7.5MG A 077920 001 Jul 19, 2006 Oct CAHN >D> AB 15MG A 077920 002 Jul 19, 2006 Oct CAHN >A> AB NOSTRUM LABS INC 7.5MG A 077920 001 Jul 19, 2006 Oct CAHN >A> AB 15MG A 077920 002 Jul 19, 2006 Oct CAHN

MEMANTINE HYDROCHLORIDE TABLET;ORAL MEMANTINE HYDROCHLORIDE >D> AB NINGBO 5MG A 212947 001 Apr 03, 2020 Oct DISC >A> @ 5MG A 212947 001 Apr 03, 2020 Oct DISC >D> AB 10MG A 212947 002 Apr 03, 2020 Oct DISC >A> @ 10MG A 212947 002 Apr 03, 2020 Oct DISC

MESALAMINE SUPPOSITORY;RECTAL MESALAMINE >D> AB APTAPHARMA INC 1GM A 207448 001 Apr 19, 2019 Oct CAHN >A> AB PHARM SOURCING 1GM A 207448 001 Apr 19, 2019 Oct CAHN

MESNA INJECTABLE;INTRAVENOUS MESNA >D> AP TEVA PHARMS USA 100MG/ML A 075764 001 Apr 27, 2001 Oct DISC >A> @ 100MG/ML A 075764 001 Apr 27, 2001 Oct DISC

Page 15 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

METAXALONE TABLET;ORAL METAXALONE >A> AB INGENUS PHARMS LLC 800MG A 213836 001 Oct 21, 2020 Oct NEWA >A> @ 800MG A 213836 001 Oct 21, 2020 Oct NEWA

METHADONE HYDROCHLORIDE CONCENTRATE;ORAL METHADONE HYDROCHLORIDE >A> AA LANNETT CO INC 10MG/ML A 212093 001 Nov 02, 2020 Oct NEWA

METHAZOLAMIDE TABLET;ORAL METHAZOLAMIDE >D> @ BAUSCH 25MG A 207438 001 Oct 05, 2018 Oct CMFD >A> AB 25MG A 207438 001 Oct 05, 2018 Oct CMFD >D> @ 50MG A 207438 002 Oct 05, 2018 Oct CMFD >A> AB 50MG A 207438 002 Oct 05, 2018 Oct CMFD

METHOTREXATE SOLUTION;SUBCUTANEOUS REDITREX >D> @ CUMBERLAND PHARMS 7.5MG/0.3ML (7.5MG/0.3ML) N 210737 001 Nov 27, 2019 Oct CMFD >A> 7.5MG/0.3ML (7.5MG/0.3ML) N 210737 001 Nov 27, 2019 Oct CMFD >A> + 7.5MG/0.3ML (7.5MG/0.3ML) N 210737 001 Nov 27, 2019 Oct CRLD >A> +! 7.5MG/0.3ML (7.5MG/0.3ML) N 210737 001 Nov 27, 2019 Oct CHRS >D> @ 10MG/0.4ML (10MG/0.4ML) N 210737 002 Nov 27, 2019 Oct CMFD >A> 10MG/0.4ML (10MG/0.4ML) N 210737 002 Nov 27, 2019 Oct CMFD >A> +! 10MG/0.4ML (10MG/0.4ML) N 210737 002 Nov 27, 2019 Oct CHRS >A> + 10MG/0.4ML (10MG/0.4ML) N 210737 002 Nov 27, 2019 Oct CRLD >D> @ 12.5MG/0.5ML (12.5MG/0.5ML) N 210737 003 Nov 27, 2019 Oct CMFD >A> 12.5MG/0.5ML (12.5MG/0.5ML) N 210737 003 Nov 27, 2019 Oct CMFD >A> + 12.5MG/0.5ML (12.5MG/0.5ML) N 210737 003 Nov 27, 2019 Oct CRLD >A> +! 12.5MG/0.5ML (12.5MG/0.5ML) N 210737 003 Nov 27, 2019 Oct CHRS >D> @ 15MG/0.6ML (15MG/0.6ML) N 210737 004 Nov 27, 2019 Oct CMFD >A> +! 15MG/0.6ML (15MG/0.6ML) N 210737 004 Nov 27, 2019 Oct CHRS >A> + 15MG/0.6ML (15MG/0.6ML) N 210737 004 Nov 27, 2019 Oct CRLD >A> 15MG/0.6ML (15MG/0.6ML) N 210737 004 Nov 27, 2019 Oct CMFD >D> @ 17.5MG/0.7ML (17.5MG/0.7ML) N 210737 005 Nov 27, 2019 Oct CMFD >A> 17.5MG/0.7ML (17.5MG/0.7ML) N 210737 005 Nov 27, 2019 Oct CMFD >A> +! 17.5MG/0.7ML (17.5MG/0.7ML) N 210737 005 Nov 27, 2019 Oct CHRS >A> + 17.5MG/0.7ML (17.5MG/0.7ML) N 210737 005 Nov 27, 2019 Oct CRLD >D> @ 20MG/0.8ML (20MG/0.8ML) N 210737 006 Nov 27, 2019 Oct CMFD >A> 20MG/0.8ML (20MG/0.8ML) N 210737 006 Nov 27, 2019 Oct CMFD >A> +! 20MG/0.8ML (20MG/0.8ML) N 210737 006 Nov 27, 2019 Oct CHRS >A> + 20MG/0.8ML (20MG/0.8ML) N 210737 006 Nov 27, 2019 Oct CRLD >D> @ 22.5MG/ML (22.5MG/ML) N 210737 007 Nov 27, 2019 Oct CMFD >A> 22.5MG/ML (22.5MG/ML) N 210737 007 Nov 27, 2019 Oct CMFD >A> +! 22.5MG/ML (22.5MG/ML) N 210737 007 Nov 27, 2019 Oct CHRS >A> + 22.5MG/ML (22.5MG/ML) N 210737 007 Nov 27, 2019 Oct CRLD >D> @ 25MG/1ML (25MG/1ML) N 210737 008 Nov 27, 2019 Oct CMFD >A> 25MG/1ML (25MG/1ML) N 210737 008 Nov 27, 2019 Oct CMFD >A> +! 25MG/1ML (25MG/1ML) N 210737 008 Nov 27, 2019 Oct CHRS >A> + 25MG/1ML (25MG/1ML) N 210737 008 Nov 27, 2019 Oct CRLD

METHYLPHENIDATE HYDROCHLORIDE FOR SUSPENSION, EXTENDED RELEASE;ORAL METHYLPHENIDATE HYDROCHLORIDE >D> @ ACTAVIS LABS FL INC 5MG/ML A 206049 001 May 17, 2018 Oct CMFD >A> AB 5MG/ML A 206049 001 May 17, 2018 Oct CMFD QUILLIVANT XR >D> +! NEXTWAVE 5MG/ML N 202100 001 Sep 27, 2012 Oct CTEC >A> AB +! 5MG/ML N 202100 001 Sep 27, 2012 Oct CTEC TABLET, CHEWABLE;ORAL METHYLPHENIDATE HYDROCHLORIDE >D> AB BRECKENRIDGE 2.5MG A 204954 001 Jan 26, 2017 Oct CAHN >D> AB 5MG A 204954 002 Jan 26, 2017 Oct CAHN >D> AB 10MG A 204954 003 Jan 26, 2017 Oct CAHN >A> AB NOSTRUM LABS INC 2.5MG A 204954 001 Jan 26, 2017 Oct CAHN >A> AB 5MG A 204954 002 Jan 26, 2017 Oct CAHN

Page 16 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

METHYLPHENIDATE HYDROCHLORIDE TABLET, CHEWABLE;ORAL METHYLPHENIDATE HYDROCHLORIDE >A> AB 10MG A 204954 003 Jan 26, 2017 Oct CAHN TABLET;ORAL METHYLPHENIDATE HYDROCHLORIDE >A> AB ACCORD HLTHCARE 5MG A 213936 001 Oct 28, 2020 Oct NEWA >A> AB 10MG A 213936 002 Oct 28, 2020 Oct NEWA >A> AB 20MG A 213936 003 Oct 28, 2020 Oct NEWA >D> AB BIONPHARMA INC 5MG A 209753 001 Mar 02, 2018 Oct CAHN >D> AB 10MG A 209753 002 Mar 02, 2018 Oct CAHN >D> AB 20MG A 209753 003 Mar 02, 2018 Oct CAHN >D> AB NOSTRUM LABS INC 5MG A 207587 001 Mar 03, 2017 Oct DISC >A> @ 5MG A 207587 001 Mar 03, 2017 Oct DISC >D> AB 10MG A 207587 002 Mar 03, 2017 Oct DISC >A> @ 10MG A 207587 002 Mar 03, 2017 Oct DISC >D> AB 20MG A 207587 003 Mar 03, 2017 Oct DISC >A> @ 20MG A 207587 003 Mar 03, 2017 Oct DISC >A> AB USPHARMA 5MG A 209753 001 Mar 02, 2018 Oct CAHN >A> AB 10MG A 209753 002 Mar 02, 2018 Oct CAHN >A> AB 20MG A 209753 003 Mar 02, 2018 Oct CAHN

METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE;ORAL METOPROLOL SUCCINATE >A> AB HETERO LABS LTD III EQ 25MG TARTRATE A 205541 001 Nov 06, 2020 Oct NEWA >A> AB EQ 50MG TARTRATE A 205541 002 Nov 06, 2020 Oct NEWA >A> AB EQ 100MG TARTRATE A 205541 003 Nov 06, 2020 Oct NEWA >A> AB EQ 200MG TARTRATE A 205541 004 Nov 06, 2020 Oct NEWA

MICAFUNGIN SODIUM INJECTABLE;INTRAVENOUS MICAFUNGIN SODIUM >A> AP APOTEX EQ 50MG BASE/VIAL A 208366 001 Nov 05, 2020 Oct NEWA >A> AP EQ 100MG BASE/VIAL A 208366 002 Nov 05, 2020 Oct NEWA

MIDAZOLAM HYDROCHLORIDE INJECTABLE;INJECTION HYDROCHLORIDE >A> @ ATLANTIDE EQ 1MG BASE/ML A 078141 001 May 30, 2008 Oct CAHN >A> @ EQ 1MG BASE/ML A 078511 001 Nov 10, 2008 Oct CAHN >A> @ EQ 5MG BASE/ML A 078141 002 May 30, 2008 Oct CAHN >A> @ EQ 5MG BASE/ML A 078511 002 Nov 10, 2008 Oct CAHN >D> AP HOSPIRA EQ 5MG BASE/ML A 075856 002 Jun 13, 2002 Oct DISC >A> @ EQ 5MG BASE/ML A 075856 002 Jun 13, 2002 Oct DISC >D> @ WOCKHARDT EQ 1MG BASE/ML A 078141 001 May 30, 2008 Oct CAHN >D> @ EQ 1MG BASE/ML A 078511 001 Nov 10, 2008 Oct CAHN >D> @ EQ 5MG BASE/ML A 078141 002 May 30, 2008 Oct CAHN >D> @ EQ 5MG BASE/ML A 078511 002 Nov 10, 2008 Oct CAHN

MILRINONE LACTATE INJECTABLE;INJECTION MILRINONE LACTATE >D> AP INTL MEDICATED EQ 1MG BASE/ML A 076013 001 Aug 02, 2002 Oct DISC >A> @ EQ 1MG BASE/ML A 076013 001 Aug 02, 2002 Oct DISC

MONTELUKAST SODIUM TABLET, CHEWABLE;ORAL MONTELUKAST SODIUM >D> AB UNICHEM EQ 4MG BASE A 208621 001 Jul 02, 2018 Oct DISC >A> @ EQ 4MG BASE A 208621 001 Jul 02, 2018 Oct DISC >D> AB EQ 5MG BASE A 208621 002 Jul 02, 2018 Oct DISC >A> @ EQ 5MG BASE A 208621 002 Jul 02, 2018 Oct DISC TABLET;ORAL MONTELUKAST SODIUM >A> AB LABORATORIOS LIOMONT EQ 10MG BASE A 205319 001 Oct 30, 2020 Oct NEWA >A> AB EQ 10MG BASE A 205319 001 Oct 30, 2020 Oct CAHN

Page 17 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MYCOPHENOLATE MOFETIL TABLET;ORAL MYCOPHENOLATE MOFETIL >A> @ AMNEAL 500MG A 090606 001 Jul 16, 2010 Oct CAHN >D> @ OXFORD PHARMS 500MG A 090606 001 Jul 16, 2010 Oct CAHN

NABUMETONE TABLET;ORAL NABUMETONE >D> AB NOSTRUM LABS INC 500MG A 090427 001 Dec 30, 2011 Oct DISC >A> @ 500MG A 090427 001 Dec 30, 2011 Oct DISC >D> AB 750MG A 090427 002 Dec 30, 2011 Oct DISC >A> @ 750MG A 090427 002 Dec 30, 2011 Oct DISC

NAFTIFINE HYDROCHLORIDE CREAM;TOPICAL NAFTIFINE HYDROCHLORIDE >D> AB GENZUM 2.0% A 210038 001 Sep 22, 2020 Oct CAHN >A> AB XIROMED 2.0% A 210038 001 Sep 22, 2020 Oct CAHN

NATAMYCIN SUSPENSION;OPHTHALMIC NATACYN >A> +! EYEVANCE 5% N 050514 001 Oct 30, 1978 Oct CAHN >D> +! NOVARTIS 5% N 050514 001 Oct 30, 1978 Oct CAHN

NATEGLINIDE TABLET;ORAL NATEGLINIDE >D> @ ALVOGEN 60MG A 205055 001 Dec 11, 2015 Oct CAHN >A> @ 60MG A 205055 001 Dec 11, 2015 Oct CAHN >D> @ 120MG A 205055 002 Dec 11, 2015 Oct CAHN >A> @ 120MG A 205055 002 Dec 11, 2015 Oct CAHN

NEBIVOLOL HYDROCHLORIDE TABLET;ORAL NEBIVOLOL HYDROCHLORIDE >A> AB HETERO LABS LTD III EQ 2.5MG BASE A 203825 001 Nov 03, 2020 Oct NEWA >A> AB EQ 5MG BASE A 203825 002 Nov 03, 2020 Oct NEWA >A> AB EQ 10MG BASE A 203825 003 Nov 03, 2020 Oct NEWA >A> AB EQ 20MG BASE A 203825 004 Nov 03, 2020 Oct NEWA

NEVIRAPINE TABLET, EXTENDED RELEASE;ORAL NEVIRAPINE >D> AB ALVOGEN 100MG A 204621 002 Nov 09, 2015 Oct CAHN >A> AB 100MG A 204621 002 Nov 09, 2015 Oct CAHN >D> AB 400MG A 204621 001 Jul 10, 2015 Oct CAHN >A> AB 400MG A 204621 001 Jul 10, 2015 Oct CAHN

NIACIN TABLET;ORAL NIACIN >D> AA WOCKHARDT 500MG A 081134 001 Apr 28, 1992 Oct DISC >A> @ 500MG A 081134 001 Apr 28, 1992 Oct DISC NIACOR >D> AA ! AVONDALE PHARMS 500MG A 040378 001 May 03, 2000 Oct CTEC >A> ! 500MG A 040378 001 May 03, 2000 Oct CTEC

NIFEDIPINE TABLET, EXTENDED RELEASE;ORAL ADALAT CC >D> AB1 + ALVOGEN 30MG N 020198 001 Apr 21, 1993 Oct DISC >A> + @ 30MG N 020198 001 Apr 21, 1993 Oct DISC >D> AB1 +! 60MG N 020198 002 Apr 21, 1993 Oct DISC >A> + @ 60MG N 020198 002 Apr 21, 1993 Oct DISC >D> AB1 +! 90MG N 020198 003 Apr 21, 1993 Oct DISC >A> + @ 90MG N 020198 003 Apr 21, 1993 Oct DISC NIFEDIPINE >D> AB1 NOVAST LABS 60MG A 202987 002 Aug 25, 2016 Oct CHRS >A> AB1 ! 60MG A 202987 002 Aug 25, 2016 Oct CHRS

Page 18 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

NIFEDIPINE TABLET, EXTENDED RELEASE;ORAL NIFEDIPINE >D> AB1 90MG A 202987 003 Aug 25, 2016 Oct CHRS >A> AB1 ! 90MG A 202987 003 Aug 25, 2016 Oct CHRS

NOREPINEPHRINE BITARTRATE INJECTABLE;INJECTION NOREPINEPHRINE BITARTRATE >A> AP FRESENIUS KABI USA EQ 1MG BASE/ML A 211382 001 Nov 03, 2020 Oct NEWA

OFLOXACIN SOLUTION/DROPS;OPHTHALMIC OFLOXACIN >D> AT AKORN 0.3% A 076407 001 Apr 15, 2008 Oct CAHN >A> AT 0.3% A 076407 001 Apr 15, 2008 Oct CAHN

OLANZAPINE INJECTABLE;INTRAMUSCULAR OLANZAPINE >A> AP AUROBINDO PHARMA LTD 10MG/VIAL A 210968 001 Oct 22, 2020 Oct NEWA

>A> OLICERIDINE >A> SOLUTION;INTRAVENOUS >A> OLINVYK >A> +! TREVENA 1MG/ML (1MG/ML) N 210730 001 Oct 30, 2020 Oct NEWA >A> +! 2MG/2ML (1MG/ML) N 210730 002 Oct 30, 2020 Oct NEWA >A> +! 30MG/30ML (1MG/ML) N 210730 003 Oct 30, 2020 Oct NEWA

OSELTAMIVIR PHOSPHATE CAPSULE;ORAL OSELTAMIVIR PHOSPHATE >D> AB SUNSHINE EQ 30MG BASE A 212739 001 Mar 04, 2020 Oct DISC >A> @ EQ 30MG BASE A 212739 001 Mar 04, 2020 Oct DISC >D> AB EQ 45MG BASE A 212739 002 Mar 04, 2020 Oct DISC >A> @ EQ 45MG BASE A 212739 002 Mar 04, 2020 Oct DISC >D> AB EQ 75MG BASE A 212739 003 Mar 04, 2020 Oct DISC >A> @ EQ 75MG BASE A 212739 003 Mar 04, 2020 Oct DISC

OXYBUTYNIN CHLORIDE TABLET, EXTENDED RELEASE;ORAL OXYBUTYNIN CHLORIDE >A> AB RUBICON 5MG A 214415 001 Oct 27, 2020 Oct NEWA >A> AB 10MG A 214415 002 Oct 27, 2020 Oct NEWA >A> AB 15MG A 214415 003 Oct 27, 2020 Oct NEWA

PALIPERIDONE TABLET, EXTENDED RELEASE;ORAL PALIPERIDONE >A> AB CSPC OUYI 1.5MG A 212807 001 Oct 29, 2020 Oct NEWA >A> AB 3MG A 212807 002 Oct 29, 2020 Oct NEWA >A> AB 6MG A 212807 003 Oct 29, 2020 Oct NEWA >A> AB 9MG A 212807 004 Oct 29, 2020 Oct NEWA >D> AB MYLAN 1.5MG A 203802 001 Sep 24, 2015 Oct CAHN >D> AB 3MG A 203802 002 Sep 24, 2015 Oct CAHN >D> AB 6MG A 203802 003 Sep 24, 2015 Oct CAHN >D> AB 9MG A 203802 004 Sep 24, 2015 Oct CAHN >A> AB RK PHARMA 1.5MG A 203802 001 Sep 24, 2015 Oct CAHN >A> AB 3MG A 203802 002 Sep 24, 2015 Oct CAHN >A> AB 6MG A 203802 003 Sep 24, 2015 Oct CAHN >A> AB 9MG A 203802 004 Sep 24, 2015 Oct CAHN

PAMIDRONATE DISODIUM INJECTABLE;INJECTION PAMIDRONATE DISODIUM >D> AP FRESENIUS KABI USA 30MG/VIAL A 075773 001 May 06, 2002 Oct DISC >A> @ 30MG/VIAL A 075773 001 May 06, 2002 Oct DISC >D> AP 30MG/10ML (3MG/ML) A 076207 001 May 17, 2002 Oct DISC >A> @ 30MG/10ML (3MG/ML) A 076207 001 May 17, 2002 Oct DISC >D> AP 90MG/VIAL A 075773 002 May 06, 2002 Oct DISC

Page 19 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PAMIDRONATE DISODIUM INJECTABLE;INJECTION PAMIDRONATE DISODIUM >A> @ 90MG/VIAL A 075773 002 May 06, 2002 Oct DISC >D> AP 90MG/10ML (9MG/ML) A 076207 002 May 17, 2002 Oct DISC >A> @ 90MG/10ML (9MG/ML) A 076207 002 May 17, 2002 Oct DISC

PHENDIMETRAZINE TARTRATE TABLET;ORAL PHENDIMETRAZINE TARTRATE >D> AA NOSTRUM LABS INC 35MG A 203600 001 Dec 27, 2017 Oct DISC >A> @ 35MG A 203600 001 Dec 27, 2017 Oct DISC

PHENOXYBENZAMINE HYDROCHLORIDE CAPSULE;ORAL PHENOXYBENZAMINE HYDROCHLORIDE >A> AB AMNEAL 10MG A 212568 001 Oct 27, 2020 Oct NEWA

PHYTONADIONE INJECTABLE;INJECTION AQUAMEPHYTON >D> + @ TELIGENT 1MG/0.5ML N 012223 002 Jul 14, 1961 Oct CAHN >A> + @ 1MG/0.5ML N 012223 002 Jul 14, 1961 Oct CAHN >D> + @ 10MG/ML N 012223 001 Jun 28, 1960 Oct CAHN >A> + @ 10MG/ML N 012223 001 Jun 28, 1960 Oct CAHN

PIOGLITAZONE HYDROCHLORIDE TABLET;ORAL PIOGLITAZONE HYDROCHLORIDE >D> AB NOSTRUM LABS INC EQ 15MG BASE A 078472 001 Feb 13, 2013 Oct DISC >A> @ EQ 15MG BASE A 078472 001 Feb 13, 2013 Oct DISC >D> AB EQ 30MG BASE A 078472 002 Feb 13, 2013 Oct DISC >A> @ EQ 30MG BASE A 078472 002 Feb 13, 2013 Oct DISC >D> AB EQ 45MG BASE A 078472 003 Feb 13, 2013 Oct DISC >A> @ EQ 45MG BASE A 078472 003 Feb 13, 2013 Oct DISC

POMALIDOMIDE CAPSULE;ORAL >A> POMALIDOMIDE >A> AB BRECKENRIDGE 1MG A 210111 001 Oct 30, 2020 Oct NFTG >A> AB 2MG A 210111 002 Oct 30, 2020 Oct NFTG >A> AB 3MG A 210111 003 Oct 30, 2020 Oct NFTG >A> AB 4MG A 210111 004 Oct 30, 2020 Oct NFTG >A> AB EUGIA PHARMA 1MG A 210249 001 Oct 30, 2020 Oct NFTG >A> AB 2MG A 210249 002 Oct 30, 2020 Oct NFTG >A> AB 3MG A 210249 003 Oct 30, 2020 Oct NFTG >A> AB 4MG A 210249 004 Oct 30, 2020 Oct NFTG POMALYST >D> + CELGENE 1MG N 204026 001 Feb 08, 2013 Oct CFTG >A> AB + 1MG N 204026 001 Feb 08, 2013 Oct CFTG >D> + 2MG N 204026 002 Feb 08, 2013 Oct CFTG >A> AB + 2MG N 204026 002 Feb 08, 2013 Oct CFTG >D> + 3MG N 204026 003 Feb 08, 2013 Oct CFTG >A> AB + 3MG N 204026 003 Feb 08, 2013 Oct CFTG >D> +! 4MG N 204026 004 Feb 08, 2013 Oct CFTG >A> AB +! 4MG N 204026 004 Feb 08, 2013 Oct CFTG

POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE;ORAL POTASSIUM CHLORIDE >A> AB1 GRANULES 10MEQ A 214452 001 Oct 21, 2020 Oct NEWA >A> AB1 20MEQ A 214452 002 Oct 21, 2020 Oct NEWA

PRAMIPEXOLE DIHYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL PRAMIPEXOLE DIHYDROCHLORIDE >D> AB ALEMBIC PHARMS LTD 0.375MG A 204518 001 Jan 02, 2019 Oct DISC >A> @ 0.375MG A 204518 001 Jan 02, 2019 Oct DISC >D> AB 0.75MG A 204518 002 Jan 02, 2019 Oct DISC >A> @ 0.75MG A 204518 002 Jan 02, 2019 Oct DISC

Page 20 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PRAMIPEXOLE DIHYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL PRAMIPEXOLE DIHYDROCHLORIDE >D> AB 1.5MG A 204518 003 Jan 02, 2019 Oct DISC >A> @ 1.5MG A 204518 003 Jan 02, 2019 Oct DISC >D> AB 2.25MG A 204518 004 Jan 02, 2019 Oct DISC >A> @ 2.25MG A 204518 004 Jan 02, 2019 Oct DISC >D> AB 3MG A 204518 005 Jan 02, 2019 Oct DISC >A> @ 3MG A 204518 005 Jan 02, 2019 Oct DISC >D> AB 3.75MG A 204518 006 Jan 02, 2019 Oct DISC >A> @ 3.75MG A 204518 006 Jan 02, 2019 Oct DISC >D> AB 4.5MG A 204518 007 Jan 02, 2019 Oct DISC >A> @ 4.5MG A 204518 007 Jan 02, 2019 Oct DISC TABLET;ORAL PRAMIPEXOLE DIHYDROCHLORIDE >D> AB ALEMBIC PHARMS LTD 0.125MG A 078894 001 Oct 08, 2010 Oct DISC >A> @ 0.125MG A 078894 001 Oct 08, 2010 Oct DISC >D> AB 0.25MG A 078894 002 Oct 08, 2010 Oct DISC >A> @ 0.25MG A 078894 002 Oct 08, 2010 Oct DISC >D> AB 0.5MG A 078894 003 Oct 08, 2010 Oct DISC >A> @ 0.5MG A 078894 003 Oct 08, 2010 Oct DISC >D> AB 1MG A 078894 004 Oct 08, 2010 Oct DISC >A> @ 1MG A 078894 004 Oct 08, 2010 Oct DISC >D> AB 1.5MG A 078894 005 Oct 08, 2010 Oct DISC >A> @ 1.5MG A 078894 005 Oct 08, 2010 Oct DISC >D> AB UNICHEM 0.125MG A 207011 001 Dec 19, 2018 Oct DISC >A> @ 0.125MG A 207011 001 Dec 19, 2018 Oct DISC >D> AB 0.25MG A 207011 002 Dec 19, 2018 Oct DISC >A> @ 0.25MG A 207011 002 Dec 19, 2018 Oct DISC >D> AB 0.5MG A 207011 003 Dec 19, 2018 Oct DISC >A> @ 0.5MG A 207011 003 Dec 19, 2018 Oct DISC >D> AB 0.75MG A 207011 004 Dec 19, 2018 Oct DISC >A> @ 0.75MG A 207011 004 Dec 19, 2018 Oct DISC >D> AB 1MG A 207011 005 Dec 19, 2018 Oct DISC >A> @ 1MG A 207011 005 Dec 19, 2018 Oct DISC >D> AB 1.5MG A 207011 006 Dec 19, 2018 Oct DISC >A> @ 1.5MG A 207011 006 Dec 19, 2018 Oct DISC

PRASUGREL HYDROCHLORIDE TABLET;ORAL EFFIENT >A> AB + DAIICHI SANKYO INC EQ 5MG BASE N 022307 001 Jul 10, 2009 Oct CAHN >A> AB +! EQ 10MG BASE N 022307 002 Jul 10, 2009 Oct CAHN >D> AB + ELI LILLY AND CO EQ 5MG BASE N 022307 001 Jul 10, 2009 Oct CAHN >D> AB +! EQ 10MG BASE N 022307 002 Jul 10, 2009 Oct CAHN

PROPAFENONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL PROPAFENONE HYDROCHLORIDE >A> AB INDICUS PHARMA 225MG A 205956 001 Jul 02, 2018 Oct CAHN >A> AB 325MG A 205956 002 Jul 02, 2018 Oct CAHN >A> AB 425MG A 205956 003 Jul 02, 2018 Oct CAHN >D> AB WILSHIRE PHARMS INC 225MG A 205956 001 Jul 02, 2018 Oct CAHN >D> AB 325MG A 205956 002 Jul 02, 2018 Oct CAHN >D> AB 425MG A 205956 003 Jul 02, 2018 Oct CAHN

PROTRIPTYLINE HYDROCHLORIDE TABLET;ORAL PROTRIPTYLINE HYDROCHLORIDE >D> AB HIKMA 10MG A 078913 002 Sep 16, 2008 Oct CHRS >A> AB ! 10MG A 078913 002 Sep 16, 2008 Oct CHRS VIVACTIL >D> AB HERITAGE PHARMA 5MG A 073644 001 Aug 24, 1995 Oct DISC >A> @ 5MG A 073644 001 Aug 24, 1995 Oct DISC >D> AB ! 10MG A 073645 001 Aug 24, 1995 Oct DISC >A> @ 10MG A 073645 001 Aug 24, 1995 Oct DISC

Page 21 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

QUETIAPINE FUMARATE TABLET;ORAL QUETIAPINE FUMARATE >D> AB ALEMBIC PHARMS LTD EQ 25MG BASE A 203390 001 Oct 28, 2014 Oct DISC >A> @ EQ 25MG BASE A 203390 001 Oct 28, 2014 Oct DISC >D> AB EQ 50MG BASE A 203390 002 Oct 28, 2014 Oct DISC >A> @ EQ 50MG BASE A 203390 002 Oct 28, 2014 Oct DISC >D> AB EQ 100MG BASE A 203390 003 Oct 28, 2014 Oct DISC >A> @ EQ 100MG BASE A 203390 003 Oct 28, 2014 Oct DISC >D> AB EQ 200MG BASE A 203390 004 Oct 28, 2014 Oct DISC >A> @ EQ 200MG BASE A 203390 004 Oct 28, 2014 Oct DISC >D> AB EQ 300MG BASE A 203390 005 Oct 28, 2014 Oct DISC >A> @ EQ 300MG BASE A 203390 005 Oct 28, 2014 Oct DISC >D> AB EQ 400MG BASE A 203390 006 Oct 28, 2014 Oct DISC >A> @ EQ 400MG BASE A 203390 006 Oct 28, 2014 Oct DISC

RAMELTEON TABLET;ORAL >A> AB APPCO 8MG A 213815 001 Oct 26, 2020 Oct NEWA

>A> REMDESIVIR >A> POWDER;INTRAVENOUS >A> VEKLURY >A> +! GILEAD SCIENCES INC 100MG/VIAL N 214787 001 Oct 22, 2020 Oct NEWA >A> SOLUTION;INTRAVENOUS >A> VEKLURY >A> +! GILEAD SCIENCES INC 100MG/20ML (5MG/ML) N 214787 002 Oct 22, 2020 Oct NEWA

REMIFENTANIL HYDROCHLORIDE INJECTABLE;INJECTION REMIFENTANIL HYDROCHLORIDE >A> AP NAVINTA LLC EQ 1MG BASE A 210594 001 Oct 13, 2020 Oct NEWA >A> AP EQ 1MG BASE/VIAL A 210594 001 Oct 13, 2020 Oct CPOT >A> AP EQ 2MG BASE A 210594 002 Oct 13, 2020 Oct NEWA >A> AP EQ 2MG BASE/VIAL A 210594 002 Oct 13, 2020 Oct CPOT >A> AP EQ 5MG BASE/VIAL A 210594 003 Oct 13, 2020 Oct CPOT >A> AP EQ 5MG BASE A 210594 003 Oct 13, 2020 Oct NEWA

REMIMAZOLAM BESYLATE POWDER;INTRAVENOUS BYFAVO >D> +! ACACIA EQ 20MG BASE/VIAL N 212295 001 Jul 02, 2020 Oct CMS1 >A> +! EQ 20MG BASE/VIAL N 212295 001 Oct 06, 2020 Oct CMS1

RIBAVIRIN CAPSULE;ORAL RIBASPHERE >A> @ CHARTWELL RX 200MG A 076203 001 Apr 06, 2004 Oct CAHN >D> @ KADMON PHARMS LLC 200MG A 076203 001 Apr 06, 2004 Oct CAHN TABLET;ORAL RIBAVIRIN >A> @ CHARTWELL RX 200MG A 077456 001 Dec 05, 2005 Oct CAHN >A> @ 400MG A 077456 002 Dec 05, 2005 Oct CAHN >A> @ 600MG A 077456 003 Dec 05, 2005 Oct CAHN >D> @ KADMON PHARMS LLC 200MG A 077456 001 Dec 05, 2005 Oct CAHN >D> @ 400MG A 077456 002 Dec 05, 2005 Oct CAHN >D> @ 600MG A 077456 003 Dec 05, 2005 Oct CAHN

RIBOFLAVIN 5'-PHOSPHATE SODIUM SOLUTION/DROPS;OPHTHALMIC PHOTREXA >D> +! AVEDRO INC 0.146% N 203324 001 Apr 15, 2016 Oct CAHN >A> +! GLAUKOS 0.146% N 203324 001 Apr 15, 2016 Oct CAHN PHOTREXA VISCOUS IN DEXTRAN 20% >D> +! AVEDRO INC 0.146% N 203324 002 Apr 15, 2016 Oct CAHN >A> +! GLAUKOS 0.146% N 203324 002 Apr 15, 2016 Oct CAHN

Page 22 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

RILUZOLE TABLET;ORAL RILUZOLE >D> AB APOTEX CORP 50MG A 091300 001 Jun 18, 2013 Oct DISC >A> @ 50MG A 091300 001 Jun 18, 2013 Oct DISC

RISPERIDONE TABLET;ORAL RISPERIDONE >A> AB AMNEAL 0.25MG A 078071 001 Jun 17, 2009 Oct CAHN >A> AB 0.5MG A 078071 002 Jun 17, 2009 Oct CAHN >A> AB 1MG A 078071 003 Jun 17, 2009 Oct CAHN >A> AB 2MG A 078071 004 Jun 17, 2009 Oct CAHN >A> AB 3MG A 078071 005 Jun 17, 2009 Oct CAHN >A> AB 4MG A 078071 006 Jun 17, 2009 Oct CAHN >D> AB OXFORD PHARMS 0.25MG A 078071 001 Jun 17, 2009 Oct CAHN >D> AB 0.5MG A 078071 002 Jun 17, 2009 Oct CAHN >D> AB 1MG A 078071 003 Jun 17, 2009 Oct CAHN >D> AB 2MG A 078071 004 Jun 17, 2009 Oct CAHN >D> AB 3MG A 078071 005 Jun 17, 2009 Oct CAHN >D> AB 4MG A 078071 006 Jun 17, 2009 Oct CAHN

RIZATRIPTAN BENZOATE TABLET;ORAL RIZATRIPTAN BENZOATE >D> AB UNICHEM EQ 5MG BASE A 207836 001 Mar 07, 2017 Oct DISC >A> @ EQ 5MG BASE A 207836 001 Mar 07, 2017 Oct DISC >D> AB EQ 10MG BASE A 207836 002 Mar 07, 2017 Oct DISC >A> @ EQ 10MG BASE A 207836 002 Mar 07, 2017 Oct DISC

SELEGILINE HYDROCHLORIDE CAPSULE;ORAL SELEGILINE HYDROCHLORIDE >D> @ DAVA PHARMS INC 5MG A 075352 001 Nov 30, 1998 Oct CAHN >A> @ NOVITIUM PHARMA 5MG A 075352 001 Nov 30, 1998 Oct CAHN

SERTRALINE HYDROCHLORIDE CONCENTRATE;ORAL SERTRALINE HYDROCHLORIDE >D> @ ACI HEALTHCARE LTD EQ 20MG BASE/ML A 076934 001 Jun 30, 2006 Oct CMFD >A> AA EQ 20MG BASE/ML A 076934 001 Jun 30, 2006 Oct CMFD

SIROLIMUS TABLET;ORAL SIROLIMUS >A> AB GLENMARK PHARMS LTD 0.5MG A 208691 001 Oct 16, 2020 Oct NEWA >A> AB 1MG A 208691 002 Oct 16, 2020 Oct NEWA >A> AB 2MG A 208691 003 Oct 16, 2020 Oct NEWA

SODIUM NITROPRUSSIDE INJECTABLE;INJECTION SODIUM NITROPRUSSIDE >A> AP XIROMED 25MG/ML A 211277 001 Oct 29, 2020 Oct NEWA

SOLIFENACIN SUCCINATE TABLET;ORAL SOLIFENACIN SUCCINATE >D> AB SUNSHINE 5MG A 213346 001 Apr 13, 2020 Oct DISC >A> @ 5MG A 213346 001 Apr 13, 2020 Oct DISC >D> AB 10MG A 213346 002 Apr 13, 2020 Oct DISC >A> @ 10MG A 213346 002 Apr 13, 2020 Oct DISC >A> AB ZYDUS PHARMS 5MG A 207721 001 Oct 19, 2020 Oct NEWA >A> AB 10MG A 207721 002 Oct 19, 2020 Oct NEWA

STAVUDINE CAPSULE;ORAL STAVUDINE >D> AUROBINDO PHARMA 15MG A 077672 003 Dec 29, 2008 Oct DISC >A> @ 15MG A 077672 003 Dec 29, 2008 Oct DISC >D> 20MG A 077672 004 Dec 29, 2008 Oct DISC

Page 23 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

STAVUDINE CAPSULE;ORAL STAVUDINE >A> @ 20MG A 077672 004 Dec 29, 2008 Oct DISC >D> 30MG A 077672 001 Dec 29, 2008 Oct DISC >A> @ 30MG A 077672 001 Dec 29, 2008 Oct DISC >D> ! 40MG A 077672 002 Dec 29, 2008 Oct DISC >A> @ 40MG A 077672 002 Dec 29, 2008 Oct DISC

SUCCINYLCHOLINE CHLORIDE INJECTABLE;INJECTION SUCCINYLCHOLINE CHLORIDE >A> AP NEXUS PHARMS 20MG/ML A 213552 001 Oct 27, 2020 Oct NEWA

TACROLIMUS CAPSULE;ORAL TACROLIMUS >A> AB BIOCON PHARMA EQ 0.5MG BASE A 212297 001 Nov 10, 2020 Oct NEWA >A> AB EQ 1MG BASE A 212297 002 Nov 10, 2020 Oct NEWA >A> AB EQ 5MG BASE A 212297 003 Nov 10, 2020 Oct NEWA >A> AB CONCORD BIOTECH LTD EQ 0.5MG BASE A 213112 001 Nov 10, 2020 Oct NEWA >A> AB EQ 1MG BASE A 213112 002 Nov 10, 2020 Oct NEWA >A> AB EQ 5MG BASE A 213112 003 Nov 10, 2020 Oct NEWA >A> AB GLENMARK PHARMS LTD EQ 0.5MG BASE A 206662 001 Nov 10, 2020 Oct NEWA >A> AB EQ 1MG BASE A 206662 002 Nov 10, 2020 Oct NEWA >A> AB EQ 5MG BASE A 206662 003 Nov 10, 2020 Oct NEWA

TADALAFIL TABLET;ORAL TADALAFIL >A> AB UMEDICA LABS PVT LTD 2.5MG A 211298 001 Oct 23, 2020 Oct NEWA >A> AB 5MG A 211298 002 Oct 23, 2020 Oct NEWA >A> AB 10MG A 211298 003 Oct 23, 2020 Oct NEWA >A> AB1 20MG A 211298 004 Oct 23, 2020 Oct NEWA >A> AB YANGLING BUCHANG 2.5MG A 208824 001 Oct 27, 2020 Oct NEWA >A> AB 5MG A 208824 002 Oct 27, 2020 Oct NEWA >A> AB 10MG A 208824 003 Oct 27, 2020 Oct NEWA >A> AB1 20MG A 208824 004 Oct 27, 2020 Oct NEWA

TAVABOROLE SOLUTION;TOPICAL KERYDIN >D> +! ANACOR PHARMS INC 5% N 204427 001 Jul 07, 2014 Oct CFTG >A> AB +! 5% N 204427 001 Jul 07, 2014 Oct CFTG TAVABOROLE >A> AB ALEOR DERMACEUTICALS 5% A 212188 001 Oct 21, 2020 Oct NEWA >A> AB ENCUBE 5% A 211297 001 Oct 13, 2020 Oct NFTG >A> AB PERRIGO PHARMA INTL 5% A 211848 001 Oct 13, 2020 Oct NFTG

TESTOSTERONE GEL;TRANSDERMAL TESTOSTERONE >D> @ PAR PHARM 25MG/2.5GM PACKET A 076744 001 May 23, 2007 Oct CMFD >A> AB1 25MG/2.5GM PACKET A 076744 001 May 23, 2007 Oct CMFD

TIMOLOL SOLUTION/DROPS;OPHTHALMIC BETIMOL >A> AT +! AKORN EQ 0.25% BASE N 020439 001 Mar 31, 1995 Oct CAHN >A> AT +! EQ 0.5% BASE N 020439 002 Mar 31, 1995 Oct CAHN >D> AT +! OAK PHARMS INC EQ 0.25% BASE N 020439 001 Mar 31, 1995 Oct CAHN >D> AT +! EQ 0.5% BASE N 020439 002 Mar 31, 1995 Oct CAHN

TIMOLOL MALEATE SOLUTION, GEL FORMING/DROPS;OPHTHALMIC TIMOLOL MALEATE >A> AB ALEMBIC PHARMS LTD EQ 0.25% BASE A 212942 001 Oct 22, 2020 Oct NEWA >A> AB EQ 0.5% BASE A 212942 002 Oct 22, 2020 Oct NEWA

Page 24 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TRANEXAMIC ACID TABLET;ORAL TRANEXAMIC ACID >D> AB MYLAN PHARMS INC 650MG A 205133 001 Sep 21, 2015 Oct DISC >A> @ 650MG A 205133 001 Sep 21, 2015 Oct DISC

TRIAMCINOLONE ACETONIDE OINTMENT;TOPICAL TRIAMCINOLONE ACETONIDE >A> AT CINTEX SVCS 0.05% A 213619 001 Nov 10, 2020 Oct NEWA

TRIAZOLAM TABLET;ORAL >A> AB RICONPHARMA LLC 0.125MG A 214219 001 Oct 20, 2020 Oct NEWA >A> AB 0.25MG A 214219 002 Oct 20, 2020 Oct NEWA

TROPICAMIDE SOLUTION/DROPS;OPHTHALMIC MYDRIACYL >A> AT ! ALCON LABS INC 1% A 084306 001 Dec 06, 1974 Oct CAHN >D> AT ! NOVARTIS PHARMS CORP 1% A 084306 001 Dec 06, 1974 Oct CAHN

TUCATINIB TABLET;ORAL TUKYSA >A> + SEAGEN 50MG N 213411 001 Apr 17, 2020 Oct CAHN >A> +! 150MG N 213411 002 Apr 17, 2020 Oct CAHN >D> + SEATTLE GENETICS 50MG N 213411 001 Apr 17, 2020 Oct CAHN >D> +! 150MG N 213411 002 Apr 17, 2020 Oct CAHN

URSODIOL CAPSULE;ORAL URSODIOL >A> AB ZYDUS 300MG A 214295 001 Oct 16, 2020 Oct NEWA

VALSARTAN TABLET;ORAL VALSARTAN >D> AB UNICHEM 40MG A 209261 001 May 04, 2018 Oct DISC >A> @ 40MG A 209261 001 May 04, 2018 Oct DISC >D> AB 80MG A 209261 002 May 04, 2018 Oct DISC >A> @ 80MG A 209261 002 May 04, 2018 Oct DISC >D> AB 160MG A 209261 003 May 04, 2018 Oct DISC >A> @ 160MG A 209261 003 May 04, 2018 Oct DISC >D> AB 320MG A 209261 004 May 04, 2018 Oct DISC >A> @ 320MG A 209261 004 May 04, 2018 Oct DISC

VANCOMYCIN HYDROCHLORIDE INJECTABLE;INJECTION VANCOMYCIN HYDROCHLORIDE >D> ! HOSPIRA EQ 1.5GM BASE/VIAL A 062912 003 Jul 10, 2020 Oct DISC >A> @ EQ 1.5GM BASE/VIAL A 062912 003 Jul 10, 2020 Oct DISC

VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL VENLAFAXINE HYDROCHLORIDE >A> AB ATLANTIDE EQ 37.5MG BASE A 078865 001 Apr 14, 2011 Oct CAHN >A> AB EQ 75MG BASE A 078865 002 Apr 14, 2011 Oct CAHN >A> AB EQ 150MG BASE A 078865 003 Apr 14, 2011 Oct CAHN >D> AB WOCKHARDT EQ 37.5MG BASE A 078865 001 Apr 14, 2011 Oct CAHN >D> AB EQ 75MG BASE A 078865 002 Apr 14, 2011 Oct CAHN >D> AB EQ 150MG BASE A 078865 003 Apr 14, 2011 Oct CAHN TABLET, EXTENDED RELEASE;ORAL VENLAFAXINE HYDROCHLORIDE >A> AB ASCENT PHARMS INC EQ 37.5MG BASE A 214419 001 Oct 21, 2020 Oct NEWA >A> AB EQ 75MG BASE A 214419 002 Oct 21, 2020 Oct NEWA >A> AB EQ 150MG BASE A 214419 003 Oct 21, 2020 Oct NEWA >A> AB EQ 225MG BASE A 214419 004 Oct 21, 2020 Oct NEWA

Page 25 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

VERAPAMIL HYDROCHLORIDE INJECTABLE;INJECTION VERAPAMIL HYDROCHLORIDE >D> ! AUROBINDO PHARMA LTD 2.5MG/ML A 212965 001 Jul 06, 2020 Oct CTEC >A> AP ! 2.5MG/ML A 212965 001 Jul 06, 2020 Oct CTEC >A> AP GLAND PHARMA LTD 2.5MG/ML A 214361 001 Oct 15, 2020 Oct NEWA >A> AP ZYDUS PHARMS 2.5MG/ML A 214215 001 Oct 15, 2020 Oct NEWA TABLET;ORAL VERAPAMIL HYDROCHLORIDE >D> AB MYLAN 80MG A 071483 002 Feb 15, 1989 Oct DISC >A> @ 80MG A 071483 002 Feb 15, 1989 Oct DISC >D> AB 120MG A 071483 001 Feb 15, 1989 Oct DISC >A> @ 120MG A 071483 001 Feb 15, 1989 Oct DISC

ZILEUTON TABLET, EXTENDED RELEASE;ORAL ZILEUTON >A> AB AIZANT 600MG A 211390 001 Oct 23, 2020 Oct NEWA

ZOLPIDEM TARTRATE TABLET;SUBLINGUAL TARTRATE >D> AB MYLAN 5MG A 202657 001 Aug 08, 2016 Oct DISC >A> @ 5MG A 202657 001 Aug 08, 2016 Oct DISC >D> AB 10MG A 202657 002 Aug 08, 2016 Oct DISC >A> @ 10MG A 202657 002 Aug 08, 2016 Oct DISC

Page 26 of 28 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

CETIRIZINE HYDROCHLORIDE TABLET;ORAL CETIRIZINE HYDROCHLORIDE ALLERGY >D> UNICHEM 5MG A 078680 003 Jun 26, 2009 Oct DISC >A> @ 5MG A 078680 003 Jun 26, 2009 Oct DISC >D> 10MG A 078680 004 Jun 26, 2009 Oct DISC >A> @ 10MG A 078680 004 Jun 26, 2009 Oct DISC CETIRIZINE HYDROCHLORIDE HIVES >D> UNICHEM 5MG A 078680 001 Jun 26, 2009 Oct DISC >A> @ 5MG A 078680 001 Jun 26, 2009 Oct DISC >D> 10MG A 078680 002 Jun 26, 2009 Oct DISC >A> @ 10MG A 078680 002 Jun 26, 2009 Oct DISC

ESOMEPRAZOLE MAGNESIUM >A> TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL >A> ESOMEPRAZOLE MAGNESIUM >A> +! DEXCEL PHARMA EQ 20MG BASE N 214278 001 Oct 20, 2020 Oct NEWA

FEXOFENADINE HYDROCHLORIDE TABLET;ORAL FEXOFENADINE HYDROCHLORIDE ALLERGY >D> @ GRANULES 60MG A 211075 001 Oct 18, 2019 Oct CMFD >A> 60MG A 211075 001 Oct 18, 2019 Oct CMFD >D> @ 180MG A 211075 002 Oct 18, 2019 Oct CMFD >A> 180MG A 211075 002 Oct 18, 2019 Oct CMFD

GUAIFENESIN TABLET, EXTENDED RELEASE;ORAL GUAIFENESIN >A> PERRIGO R AND D 1.2GM A 078912 002 Nov 05, 2020 Oct NEWA

IBUPROFEN TABLET;ORAL IBUPROFEN >A> YICHANG HUMANWELL 200MG A 214003 001 Oct 19, 2020 Oct NEWA

IBUPROFEN SODIUM TABLET;ORAL >D> IBUPROFEN SODIUM >D> PERRIGO R AND D EQ 200MG BASE A 206581 001 Aug 03, 2015 Oct DISC >A> @ EQ 200MG BASE A 206581 001 Aug 03, 2015 Oct DISC

KETOTIFEN FUMARATE SOLUTION/DROPS;OPHTHALMIC KETOTIFEN FUMARATE >D> AKORN EQ 0.025% BASE A 077958 001 Jul 26, 2007 Oct CAHN >A> EQ 0.025% BASE A 077958 001 Jul 26, 2007 Oct CAHN

LORATADINE TABLET, ORALLY DISINTEGRATING;ORAL LORATADINE >A> TENSHI 10MG A 213294 001 Oct 30, 2020 Oct NEWA

Page 27 of 28 CURRENT MONTH ADDS/DELETES LIST NOTE:

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name.

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference Standard Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred.

New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code for new approvals is NEWA.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>.

The change code description:

NEWA New drug product approval usually in the supplement month. NFTG New first time generic approval. CAHN** Applicant holder firm name has changed. CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration. CFTG Change. A first time generic for the innovator product. A TE Code is added. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug. CHRS Change. Reference Standard. CTEC Change. Therapeutic Equivalence Code. CTNA Change. Trade Name. DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the discontinued section in the next edition.

**Note: The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name and the Electronic Orange Book(EOB)query may display up to a 240 character full applicant holder firm name. An applicant holder firm name change usually changes both the collapsed name and long name. On occasion, only the long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new firm long name will display in the EOB query.

Page 28 of 28